"Gene","Gene.synonym","Ensembl","Gene.description","Uniprot","Chromosome","Position","Protein.class","Biological.process","Molecular.function","Disease.involvement","Evidence","HPA.evidence","UniProt.evidence","NeXtProt.evidence","RNA.tissue.specificity","RNA.tissue.distribution","RNA.tissue.specificity.score","RNA.tissue.specific.nTPM","RNA.single.cell.type.specificity","RNA.single.cell.type.distribution","RNA.single.cell.type.specificity.score","RNA.single.cell.type.specific.nTPM","RNA.cancer.specificity","RNA.cancer.distribution","RNA.cancer.specificity.score","RNA.cancer.specific.FPKM","RNA.brain.regional.specificity","RNA.brain.regional.distribution","RNA.brain.regional.specificity.score","RNA.brain.regional.specific.nTPM","RNA.blood.cell.specificity","RNA.blood.cell.distribution","RNA.blood.cell.specificity.score","RNA.blood.cell.specific.nTPM","RNA.blood.lineage.specificity","RNA.blood.lineage.distribution","RNA.blood.lineage.specificity.score","RNA.blood.lineage.specific.nTPM","RNA.cell.line.specificity","RNA.cell.line.distribution","RNA.cell.line.specificity.score","RNA.cell.line.specific.nTPM","RNA.tissue.cell.type.enrichment","RNA.mouse.brain.regional.specificity","RNA.mouse.brain.regional.distribution","RNA.mouse.brain.regional.specificity.score","RNA.mouse.brain.regional.specific.nTPM","RNA.pig.brain.regional.specificity","RNA.pig.brain.regional.distribution","RNA.pig.brain.regional.specificity.score","RNA.pig.brain.regional.specific.nTPM","Antibody","Reliability..IH.","Reliability..Mouse.Brain.","Reliability..IF.","Subcellular.location","Secretome.location","CCD.Protein","CCD.Transcript","Blood.concentration...Conc..blood.IM..pg.L.","Blood.concentration...Conc..blood.MS..pg.L.","Blood.expression.cluster","Tissue.expression.cluster","Cell.line.expression.cluster","Single.cell.expression.cluster","Subcellular.main.location","Subcellular.additional.location","Antibody.RRID","Pathology.prognostics...Breast.cancer","Pathology.prognostics...Cervical.cancer","Pathology.prognostics...Colorectal.cancer","Pathology.prognostics...Endometrial.cancer","Pathology.prognostics...Glioma","Pathology.prognostics...Head.and.neck.cancer","Pathology.prognostics...Liver.cancer","Pathology.prognostics...Lung.cancer","Pathology.prognostics...Melanoma","Pathology.prognostics...Ovarian.cancer","Pathology.prognostics...Pancreatic.cancer","Pathology.prognostics...Prostate.cancer","Pathology.prognostics...Renal.cancer","Pathology.prognostics...Stomach.cancer","Pathology.prognostics...Testis.cancer","Pathology.prognostics...Thyroid.cancer","Pathology.prognostics...Urothelial.cancer","ARCHS4","GTEx","TabulaSapiens","n","Transcript","CellAge","SenMayo","AgedTissue","DiseaseTissue"
"ADAMTS5","ADAMTS11, ADMP-2","ENSG00000154736","ADAM metallopeptidase with thrombospondin type 1 motif 5","Q9UNA0","21","26917922-26967088","Cancer-related genes, Predicted secreted proteins","","Hydrolase, Metalloprotease, Protease","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"placenta: 26.2","Cell type enhanced","Detected in many",NA,"Breast myoepithelial cells: 48.9;Endometrial stromal cells: 87.7;Fibroblasts: 82.0;Leydig cells: 63.0;Smooth muscle cells: 50.0;Theca cells: 37.4","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Sarcoma: 7.4;thyroid cancer: 4.8","Liver - Hepatic stellate cells","Low region specificity","Detected in some",NA,"","Low region specificity","Detected in some",NA,"","HPA005661, CAB025996, HPA030906, HPA030908","Approved","","Supported","Nucleoplasm","Secreted to extracellular matrix",NA,NA,NA,28000,"","Cluster 5: Breast - Unknown function","Cluster 20: Connective tissue cells - ECM organization","Cluster 65: Fibroblasts - ECM organization","Nucleoplasm","","CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655","unprognostic (1.97e-1)","unprognostic (2.88e-3)","unprognostic (2.69e-2)","unprognostic (4.01e-2)","unprognostic (4.67e-1)","unprognostic (2.10e-2)","unprognostic (4.38e-8)","unprognostic (1.11e-3)","unprognostic (7.66e-2)","unprognostic (6.17e-2)","unprognostic (8.13e-2)","unprognostic (7.76e-2)","prognostic unfavorable (2.46e-4)","unprognostic (6.69e-3)","unprognostic (3.01e-1)","prognostic unfavorable (8.54e-4)","unprognostic (1.15e-1)",10,0,2,12,NA,1,0,NA,NA
"ADAMTS8","ADAM-TS8, FLJ41712, METH2","ENSG00000134917","ADAM metallopeptidase with thrombospondin type 1 motif 8","Q9UP79","11","130404923-130428609","Cancer-related genes, Plasma proteins, Predicted secreted proteins","","Heparin-binding, Hydrolase, Metalloprotease, Protease","Cancer-related genes","Evidence at protein level","Evidence at transcript level","Evidence at transcript level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"lung: 27.6","Cell type enhanced","Detected in some",NA,"Endometrial ciliated cells: 10.4;Endometrial stromal cells: 32.6;Fibroblasts: 18.6;Glandular and luminal cells: 27.3;Schwann cells: 9.7","Cancer enhanced","Detected in many",NA,"endometrial cancer: 5.7","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in single",NA,"cervical cancer: 2.5","","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","HPA066349","Approved","","","","Secreted to extracellular matrix",NA,NA,NA,3600000,"","Cluster 19: Lung - Lung function","Cluster 20: Connective tissue cells - ECM organization","Cluster 14: Endometrium - Transcription regulation","","","HPA066349: AB_2685662","unprognostic (4.76e-6)","unprognostic (3.92e-2)","unprognostic (6.13e-2)","prognostic favorable (1.38e-4)","unprognostic (2.41e-1)","unprognostic (7.81e-2)","unprognostic (3.09e-2)","unprognostic (9.83e-2)","unprognostic (1.09e-4)","unprognostic (3.05e-1)","unprognostic (1.50e-1)","unprognostic (2.40e-1)","unprognostic (4.66e-3)","unprognostic (4.03e-3)","unprognostic (5.23e-1)","unprognostic (1.05e-1)","unprognostic (2.41e-1)",7,0,3,10,NA,0,0,"Nerve",NA
"ANGPT1","Ang1, KIAA0003","ENSG00000154188","Angiopoietin 1","Q15389","8","107249482-107498055","Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins","Angiogenesis, Differentiation","Developmental protein","Cancer-related genes, Disease variant","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"seminal vesicle: 33.5","Cell type enhanced","Detected in many",NA,"Astrocytes: 58.5;Fibroblasts: 30.0;Inhibitory neurons: 36.8;Serous glandular cells: 32.8;Smooth muscle cells: 51.4","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","Immune cell enriched","Detected in some",5,"neutrophil: 5.8","Lineage enriched","Detected in many",5,"granulocytes: 5.8","Cancer enhanced","Detected in many",NA,"Rhabdoid: 43.8","Heart muscle - Smooth muscle cells, Liver - Hepatic stellate cells, Lung - Fibroblast_1","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","CAB017815, HPA018793, HPA018816","Approved","","","","Secreted to blood",NA,NA,3.2e+07,110000,"Cluster 1: Neutrophils - Mixed function","Cluster 82: Adipose tissue - ECM organization","Cluster 66: Myeloid cells - Innate immune response","Cluster 72: Smooth muscle cells - ECM organization","","","CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821","unprognostic (7.71e-2)","unprognostic (2.13e-1)","unprognostic (6.37e-2)","unprognostic (4.11e-3)","unprognostic (7.36e-2)","unprognostic (3.80e-2)","unprognostic (2.22e-3)","unprognostic (3.29e-2)","unprognostic (1.07e-2)","unprognostic (5.54e-2)","unprognostic (2.62e-1)","unprognostic (1.44e-1)","prognostic favorable (4.40e-4)","unprognostic (4.56e-3)","unprognostic (1.69e-1)","unprognostic (3.24e-1)","unprognostic (1.76e-1)",8,0,3,11,"ENST00000520052",1,1,NA,NA
"BDNF","","ENSG00000176697","Brain derived neurotrophic factor","P23560","11","27654893-27722058","Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins","","Growth factor","Cancer-related genes, Disease variant","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in some",NA,"brain: 8.2","Cell type enhanced","Detected in many",NA,"Alveolar cells type 1: 20.7;Bipolar cells: 9.8;Cardiomyocytes: 11.6;Excitatory neurons: 22.0;Skeletal myocytes: 7.9;Smooth muscle cells: 13.1;Theca cells: 8.1","Low cancer specificity","Detected in some",NA,"","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","Lung - Alveolar cells type 1, Testis - Early spermatids","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","CAB009564","Enhanced","","","","Secreted to blood",NA,"Yes",1.6e+07,24000,"","Cluster 10: Brain - Neuronal signaling","Cluster 20: Connective tissue cells - ECM organization","Cluster 18: Non-specific - Mixed function","","","CAB009564: AB_2064213","unprognostic (1.25e-2)","unprognostic (2.84e-1)","unprognostic (4.35e-2)","unprognostic (2.54e-2)","unprognostic (1.01e-2)","unprognostic (6.82e-2)","unprognostic (2.39e-2)","unprognostic (2.21e-1)","unprognostic (3.20e-1)","unprognostic (1.78e-1)","unprognostic (1.22e-2)","unprognostic (2.65e-1)","unprognostic (3.22e-2)","unprognostic (3.88e-2)","unprognostic (5.88e-2)","unprognostic (1.40e-1)","unprognostic (2.84e-3)",12,12,12,36,"ENST00000356660; ENST00000530786; ENST00000533131; ENST00000584049",0,0,NA,NA
"CEMIP","HYBID, IR2155535, KIAA1199, TMEM2L","ENSG00000103888","Cell migration inducing hyaluronidase 1","Q8WUJ3","15","80779343-80951776","Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","Glycosidase, Hydrolase","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"choroid plexus: 25.3;endometrium 1: 31.9","Group enriched","Detected in some",8,"Excitatory neurons: 61.7;Inhibitory neurons: 39.4;Microglial cells: 98.5;Thymic epithelial cells: 68.9","Cancer enhanced","Detected in all",NA,"colorectal cancer: 21.3","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in all",NA,"","Testis - Sertoli cells","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA079449","","","Supported","Nuclear membrane,Nucleoli fibrillar center,Endoplasmic reticulum","Secreted in other tissues",NA,NA,NA,1700000,"Cluster 4: T-regs - Cell cycle regulation","Cluster 42: Ciliated cells - Cilium & Cell projection","Cluster 20: Connective tissue cells - ECM organization","Cluster 38: Neurons - Neuronal signaling","Nucleoli fibrillar center","Nuclear membrane, Endoplasmic reticulum","HPA079449: ","unprognostic (1.14e-3)","unprognostic (6.80e-2)","unprognostic (5.95e-2)","unprognostic (3.15e-3)","unprognostic (3.49e-3)","unprognostic (6.80e-2)","unprognostic (5.47e-2)","unprognostic (1.22e-1)","unprognostic (7.49e-2)","unprognostic (1.53e-1)","unprognostic (7.24e-2)","unprognostic (1.36e-1)","unprognostic (5.27e-10)","unprognostic (1.82e-2)","unprognostic (1.93e-1)","unprognostic (1.34e-1)","prognostic unfavorable (2.65e-4)",9,9,11,29,"ENST00000220244; ENST00000356249; ENST00000394685; ENST00000495041",0,0,"Adipose; Blood.Vessel",NA
"COL11A1","CO11A1, COLL6, DFNA37, STL2","ENSG00000060718","Collagen type XI alpha 1 chain","P12107","1","102876467-103108872","Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","","Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in some",NA,"placenta: 20.1;retina: 9.6","Cell type enriched","Detected in some",5,"Oligodendrocyte precursor cells: 533.8","Cancer enhanced","Detected in many",NA,"breast cancer: 27.4","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Rhabdoid: 246.1","Skeletal muscle - Fibroblasts, Testis - Early spermatids, Testis - Late spermatids","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","HPA058335","","","Supported","Endoplasmic reticulum","Secreted to extracellular matrix","No","No",NA,640000,"","Cluster 28: Placenta - Pregnancy","Cluster 33: Skin cancer - Membrane components","Cluster 10: Neurons & Oligodendrocytes - Nervous system development","Endoplasmic reticulum","","HPA058335: AB_2683682","unprognostic (2.60e-3)","unprognostic (6.61e-4)","unprognostic (9.58e-2)","unprognostic (5.06e-5)","unprognostic (2.83e-1)","unprognostic (2.85e-2)","unprognostic (6.03e-3)","unprognostic (2.23e-3)","unprognostic (9.08e-2)","unprognostic (1.21e-1)","unprognostic (1.12e-2)","unprognostic (1.94e-2)","unprognostic (3.01e-12)","unprognostic (1.27e-2)","unprognostic (3.53e-1)","unprognostic (3.54e-2)","unprognostic (2.32e-2)",9,7,9,25,"ENST00000512756",0,0,"Adipose; Blood.Vessel",NA
"COL15A1","","ENSG00000204291","Collagen type XV alpha 1 chain","P39059","9","98943179-99070792","Plasma proteins, Predicted secreted proteins","Angiogenesis, Cell adhesion, Differentiation","Developmental protein","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"placenta: 229.2","Cell type enhanced","Detected in many",NA,"Adipocytes: 297.0;Endothelial cells: 185.7;Fibroblasts: 165.0;Leydig cells: 330.9;Peritubular cells: 467.1;Theca cells: 317.4","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in some",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Sarcoma: 14.8;skin cancer: 17.3","Adipose visceral - Endothelial cells, Colon - Smooth muscle cells, Heart muscle - Fibroblasts, Lung - Fibroblast_2, Skin - Fibroblast_1, Testis - Peritubular cells","Low region specificity","Detected in many",NA,"","Region enriched","Detected in many",7,"spinal cord: 44.3","HPA017913, HPA017915","Enhanced","","Approved","Endoplasmic reticulum","Secreted to extracellular matrix",NA,NA,NA,2.8e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Endoplasmic reticulum","","HPA017913: AB_1847099, HPA017915: AB_1847100","unprognostic (4.30e-1)","unprognostic (1.44e-1)","unprognostic (1.41e-1)","unprognostic (2.22e-2)","unprognostic (2.09e-1)","unprognostic (1.09e-2)","prognostic favorable (5.47e-4)","unprognostic (3.08e-2)","unprognostic (1.05e-1)","unprognostic (2.29e-1)","unprognostic (1.84e-1)","unprognostic (7.87e-2)","unprognostic (1.20e-3)","unprognostic (3.66e-3)","unprognostic (8.98e-2)","unprognostic (6.98e-2)","prognostic unfavorable (3.08e-4)",5,0,5,10,NA,0,0,"Muscle","Idiopathic.Pulmonary.Fibrosis"
"COL1A1","OI4","ENSG00000108821","Collagen type I alpha 1 chain","P02452","17","50184101-50201632","Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","","Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 1331.8;gallbladder: 1211.3","Cell type enhanced","Detected in many",NA,"Endometrial stromal cells: 1863.1;Fibroblasts: 1830.1;Leydig cells: 557.7;Pancreatic endocrine cells: 1576.7;Smooth muscle cells: 657.2","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"Brain cancer: 1245.5","Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Stomach - Fibroblasts, Thyroid - Fibroblasts","Low region specificity","Detected in all",NA,"","Region enhanced","Detected in all",NA,"spinal cord: 115.9","HPA011795, HPA012111","Approved","","Approved","Endoplasmic reticulum,Vesicles","Secreted to extracellular matrix",NA,NA,NA,8e+07,"","Cluster 46: Fibroblasts - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Endoplasmic reticulum","Vesicles","HPA011795: AB_1847088, HPA012111: ","unprognostic (1.61e-1)","unprognostic (3.60e-3)","unprognostic (8.29e-2)","unprognostic (5.52e-2)","unprognostic (7.74e-2)","unprognostic (2.22e-1)","unprognostic (6.01e-2)","prognostic unfavorable (4.43e-4)","unprognostic (1.23e-2)","unprognostic (2.55e-2)","unprognostic (8.53e-2)","unprognostic (9.90e-2)","prognostic unfavorable (7.19e-12)","unprognostic (2.74e-2)","unprognostic (4.73e-2)","unprognostic (7.26e-2)","unprognostic (3.87e-3)",8,0,11,19,"ENST00000474644",0,0,"Brain","Idiopathic.Pulmonary.Fibrosis"
"COL1A2","OI4","ENSG00000164692","Collagen type I alpha 2 chain","P08123","7","94394895-94431227","Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins","","","Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"cervix: 1831.7;gallbladder: 1378.0;smooth muscle: 1416.9","Cell type enhanced","Detected in many",NA,"Endometrial stromal cells: 711.3;Fibroblasts: 1913.7;Glandular and luminal cells: 452.3;Leydig cells: 999.0;Pancreatic endocrine cells: 498.1;Peritubular cells: 495.5;Smooth muscle cells: 640.7;Theca cells: 555.0","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"Brain cancer: 1492.3","Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Stomach - Fibroblasts","Low region specificity","Detected in all",NA,"","Region enhanced","Detected in all",NA,"spinal cord: 133.7","CAB032650, HPA068464, HPA068494","Approved","","Supported","Endoplasmic reticulum","Secreted to extracellular matrix",NA,NA,NA,2.7e+07,"","Cluster 46: Fibroblasts - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Endoplasmic reticulum","","CAB032650: AB_2082039, HPA068464: , HPA068494: ","unprognostic (1.20e-1)","unprognostic (6.34e-2)","unprognostic (1.32e-1)","unprognostic (3.40e-2)","unprognostic (2.86e-2)","unprognostic (2.81e-1)","unprognostic (5.15e-2)","unprognostic (7.38e-3)","unprognostic (2.01e-2)","unprognostic (1.40e-2)","unprognostic (5.83e-2)","unprognostic (2.15e-1)","prognostic unfavorable (1.51e-9)","unprognostic (1.35e-2)","unprognostic (5.25e-2)","unprognostic (1.15e-1)","unprognostic (3.31e-3)",11,0,12,23,"ENST00000620463",0,0,NA,"Idiopathic.Pulmonary.Fibrosis"
"COL3A1","EDS4A","ENSG00000168542","Collagen type III alpha 1 chain","P02461","2","188974373-189012746","Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","","Aortic aneurysm, Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 2369.0;gallbladder: 2092.8;placenta: 1981.7;smooth muscle: 2140.7","Group enriched","Detected in many",4,"Endometrial stromal cells: 2622.9;Fibroblasts: 1426.6;Smooth muscle cells: 709.7;Theca cells: 729.0","Low cancer specificity","Detected in all",NA,"","Group enriched","Detected in all",4,"cerebral cortex: 15.0;thalamus: 10.9;white matter: 4.6","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Rhabdoid: 1260.1;testis cancer: 954.8","Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1","Low region specificity","Detected in all",NA,"","Region enhanced","Detected in all",NA,"spinal cord: 61.1","HPA007583, CAB016766, CAB059993","Approved","","Approved","Endoplasmic reticulum","Secreted to extracellular matrix",NA,NA,NA,3.2e+07,"","Cluster 46: Fibroblasts - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Endoplasmic reticulum","","CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548","unprognostic (1.12e-1)","unprognostic (2.03e-2)","unprognostic (1.02e-1)","unprognostic (6.01e-2)","unprognostic (2.78e-1)","unprognostic (2.04e-1)","unprognostic (6.94e-2)","unprognostic (6.77e-3)","unprognostic (3.57e-3)","unprognostic (2.60e-2)","unprognostic (1.89e-2)","unprognostic (1.99e-1)","prognostic unfavorable (3.59e-10)","unprognostic (1.70e-3)","unprognostic (3.76e-2)","unprognostic (7.61e-2)","unprognostic (6.17e-3)",10,0,11,21,"ENST00000317840",0,0,NA,"Idiopathic.Pulmonary.Fibrosis"
"COL4A5","ASLN, ATS","ENSG00000188153","Collagen type IV alpha 5 chain","P29400","X","108439838-108697545","Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins","","","Alport syndrome, Cancer-related genes, Deafness, Disease variant","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"brain: 102.9","Cell type enriched","Detected in many",9,"Oligodendrocytes: 673.9","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"testis cancer: 65.6","Adipose subcutaneous - Smooth muscle cells","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA077177","","","Approved","Vesicles,Plasma membrane","Secreted to extracellular matrix",NA,NA,NA,NA,"","Cluster 57: Non-specific - Angiogenesis","Cluster 60: Keratinocytes - Epithelial cell function","Cluster 8: Oligodendrocytes - Myelin sheath organization","Plasma membrane","Vesicles","HPA077177: ","unprognostic (2.58e-2)","unprognostic (2.57e-2)","unprognostic (3.64e-2)","unprognostic (3.98e-2)","unprognostic (1.11e-1)","unprognostic (1.61e-1)","unprognostic (1.97e-2)","unprognostic (7.27e-2)","unprognostic (2.70e-1)","unprognostic (2.20e-1)","unprognostic (1.60e-1)","unprognostic (1.26e-1)","prognostic unfavorable (2.41e-5)","unprognostic (2.10e-3)","unprognostic (1.70e-1)","unprognostic (2.61e-2)","unprognostic (1.06e-1)",2,0,9,11,NA,0,0,NA,NA
"COL5A1","","ENSG00000130635","Collagen type V alpha 1 chain","P20908","9","134641803-134844843","Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","Heparin-binding","Cancer-related genes, Disease variant, Ehlers-Danlos syndrome","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"cervix: 146.6","Cell type enhanced","Detected in many",NA,"Endometrial stromal cells: 129.4;Fibroblasts: 126.5;Leydig cells: 61.6;Pancreatic endocrine cells: 61.8;Schwann cells: 50.9;Smooth muscle cells: 54.7","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Brain cancer: 233.0","Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Lung - Fibroblast_2, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Stomach - Fibroblasts","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","HPA030769","Approved","","Approved","Vesicles","Secreted to extracellular matrix","No","No",NA,1.5e+07,"","Cluster 46: Fibroblasts - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Vesicles","","HPA030769: AB_2673603","unprognostic (7.77e-2)","unprognostic (4.55e-3)","unprognostic (2.22e-2)","unprognostic (2.33e-1)","prognostic unfavorable (9.56e-4)","unprognostic (8.07e-2)","unprognostic (8.09e-2)","unprognostic (2.38e-3)","unprognostic (1.54e-2)","unprognostic (5.03e-3)","unprognostic (5.05e-2)","unprognostic (1.40e-1)","prognostic unfavorable (2.07e-12)","unprognostic (2.02e-2)","unprognostic (4.73e-2)","unprognostic (1.65e-2)","unprognostic (2.50e-3)",5,0,11,16,NA,0,0,NA,"Idiopathic.Pulmonary.Fibrosis"
"COL6A3","","ENSG00000163359","Collagen type VI alpha 3 chain","P12111","2","237324003-237414207","Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion","Protease inhibitor, Serine protease inhibitor","Congenital muscular dystrophy, Disease variant, Dystonia, Limb-girdle muscular dystrophy","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"smooth muscle: 391.3","Cell type enhanced","Detected in many",NA,"Cardiomyocytes: 213.4;Endometrial stromal cells: 331.7;Fibroblasts: 695.7;Leydig cells: 305.8;Smooth muscle cells: 181.0","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Brain cancer: 354.0","Kidney - Fibroblasts, Liver - Hepatic stellate cells, Skin - Fibroblast_2","Region enhanced","Detected in some",NA,"basal ganglia: 4.5","Region enriched","Detected in many",4,"spinal cord: 12.0","HPA010007, HPA010080","Supported","","Approved","Endoplasmic reticulum,Vesicles","Secreted to extracellular matrix",NA,NA,NA,1e+09,"","Cluster 46: Fibroblasts - ECM organization","Cluster 59: Fibroblasts - Metabolism","Cluster 65: Fibroblasts - ECM organization","Endoplasmic reticulum","Vesicles","HPA010007: , HPA010080: AB_1078550","unprognostic (8.94e-2)","unprognostic (7.24e-2)","unprognostic (6.60e-2)","unprognostic (3.82e-1)","unprognostic (3.90e-2)","unprognostic (2.37e-1)","unprognostic (5.34e-2)","unprognostic (2.87e-2)","unprognostic (8.20e-3)","unprognostic (2.55e-2)","unprognostic (1.33e-2)","unprognostic (1.23e-1)","prognostic unfavorable (5.57e-11)","unprognostic (1.54e-2)","unprognostic (2.50e-2)","unprognostic (3.51e-2)","unprognostic (1.84e-3)",9,0,12,21,"ENST00000353578",0,0,"Muscle","Idiopathic.Pulmonary.Fibrosis"
"COL7A1","EBD1, EBDCT, EBR1","ENSG00000114270","Collagen type VII alpha 1 chain","Q02388","3","48564073-48595329","Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion","Protease inhibitor, Serine protease inhibitor","Disease variant, Epidermolysis bullosa","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"skin 1: 98.2","Cell type enhanced","Detected in many",NA,"Basal keratinocytes: 64.9;Basal respiratory cells: 59.2;Basal squamous epithelial cells: 44.3;Endometrial stromal cells: 39.1","Cancer enhanced","Detected in all",NA,"head and neck cancer: 41.7","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","Heart muscle - Cardiomyocytes, Kidney - Endothelial cells","","",NA,"","","",NA,"","CAB016357, HPA018877, HPA042420","Enhanced","","Approved","Endoplasmic reticulum,Vesicles","Secreted to extracellular matrix",NA,NA,NA,6000,"Cluster 41: Basophils - Cellular respiration","Cluster 31: Skin - Epidermis development","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 22: Squamous epithelial cells - Keratinization","Endoplasmic reticulum","Vesicles","CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990","unprognostic (2.69e-2)","unprognostic (4.11e-1)","unprognostic (1.35e-1)","unprognostic (3.47e-1)","unprognostic (4.93e-2)","prognostic favorable (6.31e-4)","unprognostic (7.56e-2)","unprognostic (1.25e-2)","unprognostic (5.59e-2)","unprognostic (2.98e-1)","prognostic unfavorable (3.86e-4)","unprognostic (3.74e-2)","unprognostic (0.00e+0)","unprognostic (1.76e-1)","unprognostic (1.38e-1)","unprognostic (1.04e-1)","unprognostic (3.86e-2)",5,0,9,14,NA,0,0,"Lung; Muscle; Nerve",NA
"COLEC10","CL-L1","ENSG00000184374","Collectin subfamily member 10","Q9Y6Z7","8","118995452-119108455","Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins","","","Disease variant","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in some",6,"liver: 65.7","Cell type enhanced","Detected in some",NA,"Cardiomyocytes: 3.8;Excitatory neurons: 6.8;Inhibitory neurons: 5.3;Kupffer cells: 3.0;Oligodendrocyte precursor cells: 2.4;Oligodendrocytes: 4.5","Cancer enhanced","Detected in some",NA,"liver cancer: 1.1","Not detected","Not detected",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in some",NA,"Kidney cancer: 9.9;Neuroblastoma: 10.2","Liver - Hepatic stellate cells","Not detected","Not detected",NA,"","Low region specificity","Detected in many",NA,"","","","","","","Secreted to blood",NA,NA,NA,3e+07,"","Cluster 85: Liver - Metabolism","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","","","","unprognostic (1.28e-1)","unprognostic (1.29e-2)","unprognostic (3.79e-4)","unprognostic (6.25e-3)","unprognostic (1.80e-3)","unprognostic (7.73e-2)","prognostic favorable (5.79e-4)","unprognostic (1.05e-1)","","unprognostic (1.61e-1)","unprognostic (1.13e-1)","unprognostic (9.25e-2)","unprognostic (9.02e-5)","unprognostic (2.47e-1)","unprognostic (1.82e-1)","unprognostic (5.85e-5)","unprognostic (7.12e-2)",9,9,8,26,"ENST00000332843",0,0,NA,NA
"CPA4","CPA3","ENSG00000128510","Carboxypeptidase A4","Q9UI42","7","130293134-130324180","Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","Carboxypeptidase, Hydrolase, Metalloprotease, Protease","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"esophagus: 21.6;skin 1: 57.1","Cell type enhanced","Detected in some",NA,"Basal keratinocytes: 12.0;Basal respiratory cells: 23.8;Exocrine glandular cells: 46.9;Squamous epithelial cells: 11.6;Suprabasal keratinocytes: 20.1","Cancer enhanced","Detected in many",NA,"cervical cancer: 10.0;head and neck cancer: 9.8","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Bone cancer: 165.5","Adipose visceral - Mesothelial cells","Not detected","Not detected",NA,"","Not detected","Not detected",NA,"","HPA021030","","","Approved","Nucleoplasm,Centrosome,Cytosol","Secreted in other tissues",NA,"Yes",NA,390000,"","Cluster 31: Skin - Epidermis development","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 74: Pancreatic cells - Mixed function","Nucleoplasm","Centrosome, Cytosol","HPA021030: AB_1846010","unprognostic (7.60e-3)","unprognostic (4.00e-2)","unprognostic (1.59e-3)","unprognostic (3.63e-3)","unprognostic (2.24e-2)","unprognostic (2.91e-2)","unprognostic (2.78e-2)","unprognostic (4.36e-3)","unprognostic (3.23e-1)","unprognostic (5.79e-2)","unprognostic (2.37e-3)","unprognostic (6.49e-2)","unprognostic (6.21e-10)","unprognostic (2.39e-1)","unprognostic (1.67e-1)","unprognostic (7.56e-2)","prognostic unfavorable (1.31e-4)",10,13,13,36,"ENST00000222482; ENST00000493259",1,0,NA,NA
"CTHRC1","","ENSG00000164932","Collagen triple helix repeat containing 1","Q96CG8","8","103371538-103382989","Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"adipose tissue: 69.1;gallbladder: 87.8;placenta: 90.1;urinary bladder: 84.6","Cell type enhanced","Detected in many",NA,"Endothelial cells: 83.3;Fibroblasts: 154.2;Pancreatic endocrine cells: 68.7;Smooth muscle cells: 53.6","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Immune cell enhanced","Detected in single",NA,"NK-cell: 2.3","Low lineage specificity","Detected in single",NA,"","Cancer enhanced","Detected in all",NA,"skin cancer: 179.1","Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA059806, HPA061896","Approved","","Approved","Nucleoplasm","Secreted in other tissues",NA,NA,NA,420000,"Cluster 40: NK-cells - Unknown function","Cluster 28: Placenta - Pregnancy","Cluster 33: Skin cancer - Membrane components","Cluster 53: Connective tissue cells - ECM organization","Nucleoplasm","","HPA059806: AB_2684130, HPA061896: AB_2684633","unprognostic (2.04e-2)","unprognostic (4.58e-1)","unprognostic (2.76e-2)","unprognostic (1.88e-2)","unprognostic (1.20e-1)","unprognostic (1.33e-2)","prognostic unfavorable (1.67e-4)","unprognostic (4.17e-2)","unprognostic (3.64e-2)","unprognostic (8.63e-2)","unprognostic (1.12e-2)","unprognostic (3.73e-2)","prognostic unfavorable (1.22e-14)","unprognostic (2.33e-3)","unprognostic (3.21e-2)","unprognostic (7.96e-3)","unprognostic (2.37e-3)",8,5,3,16,"ENST00000520337",0,0,"Adipose; Blood.Vessel; Muscle","Idiopathic.Pulmonary.Fibrosis"
"DKK1","DKK-1, SK","ENSG00000107984","Dickkopf WNT signaling pathway inhibitor 1","O94907","10","52314281-52318042","Predicted secreted proteins","Wnt signaling pathway","Developmental protein","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 34.0;placenta: 48.9","Cell type enriched","Detected in many",4,"Endometrial stromal cells: 356.9","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","Skin - Macrophages","Not detected","Not detected",NA,"","Low region specificity","Detected in single",NA,"","","","","","","Secreted in other tissues",NA,NA,NA,NA,"","Cluster 82: Adipose tissue - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 52: Endometrial stromal cells - ECM organization","","","","unprognostic (5.65e-2)","unprognostic (4.21e-2)","unprognostic (7.09e-2)","unprognostic (7.99e-2)","unprognostic (1.31e-1)","prognostic unfavorable (4.35e-8)","unprognostic (7.93e-2)","prognostic unfavorable (7.80e-6)","unprognostic (1.54e-1)","unprognostic (6.87e-2)","prognostic unfavorable (1.27e-4)","unprognostic (1.81e-1)","unprognostic (1.68e-1)","unprognostic (7.47e-3)","unprognostic (4.05e-1)","unprognostic (1.19e-1)","unprognostic (2.06e-2)",5,10,5,20,NA,0,1,"Blood.Vessel",NA
"DKK3","REIC, RIG","ENSG00000050165","Dickkopf WNT signaling pathway inhibitor 3","Q9UBP4","11","11956207-12009769","Plasma proteins, Predicted secreted proteins","Wnt signaling pathway","Developmental protein","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in many",6,"heart muscle: 1224.0","Group enriched","Detected in many",9,"Cardiomyocytes: 889.2;Muller glia cells: 1843.7","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Immune cell enhanced","Detected in some",NA,"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8","Lineage enriched","Detected in single",62,"T-cells: 6.2","Cancer enhanced","Detected in many",NA,"Brain cancer: 325.0","Breast - Breast myoepithelial cells, Colon - Enteric glia cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblast_1, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Stomach - Fibroblasts, Testis - Sertoli cells, Thyroid - Fibroblasts","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA011868, CAB024949","Approved","","Supported","Nuclear bodies,Vesicles,Cytosol","Secreted in other tissues","No","No",NA,1.8e+07,"Cluster 16: MAIT-cells - Unknown function","Cluster 44: Heart - Cardiac muscle contraction","Cluster 20: Connective tissue cells - ECM organization","Cluster 68: Muller glia cells - Visual perception","Vesicles","Nuclear bodies, Cytosol","CAB024949: , HPA011868: AB_1847716","unprognostic (4.24e-2)","unprognostic (6.40e-2)","unprognostic (1.96e-1)","unprognostic (7.84e-2)","unprognostic (3.06e-3)","unprognostic (6.58e-3)","unprognostic (1.14e-2)","unprognostic (1.58e-1)","unprognostic (3.31e-3)","unprognostic (5.28e-2)","unprognostic (4.51e-2)","unprognostic (3.87e-2)","prognostic unfavorable (6.31e-5)","unprognostic (7.41e-3)","unprognostic (1.09e-1)","unprognostic (2.97e-2)","unprognostic (1.02e-3)",11,0,12,23,"ENST00000532873; ENST00000534511",0,0,NA,NA
"DPP4","ADCP2, CD26, DPPIV","ENSG00000197635","Dipeptidyl peptidase 4","P27487","2","161992245-162074394","CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion, Host-virus interaction","Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease","FDA approved drug targets","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3","Cell type enhanced","Detected in many",NA,"Cytotrophoblasts: 136.3;Prostatic glandular cells: 199.1;Proximal enterocytes: 281.4;Serous glandular cells: 123.3;Syncytiotrophoblasts: 169.5","Cancer enhanced","Detected in all",NA,"prostate cancer: 55.2","Not detected","Not detected",NA,"","Immune cell enhanced","Detected in many",NA,"MAIT T-cell: 52.3","Lineage enriched","Detected in many",10,"T-cells: 52.3","Low cancer specificity","Detected in many",NA,"","Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Prostate - Prostate glandular cells, Skin - Fibroblast_2, Testis - Early spermatids","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","CAB045970, HPA068778, HPA071236","Enhanced","","","","Secreted to blood",NA,NA,NA,1.9e+08,"Cluster 16: MAIT-cells - Unknown function","Cluster 87: Intestine & Kidney - Transmembrane transport","Cluster 10: Ovarian & Endometrial cancers - Unknown function","Cluster 40: Plasma cells - Humoral immune response","","","CAB045970: AB_11140529, HPA068778: , HPA071236: ","unprognostic (4.47e-2)","unprognostic (4.47e-2)","unprognostic (8.89e-2)","unprognostic (3.36e-1)","unprognostic (7.25e-2)","unprognostic (5.40e-2)","unprognostic (2.78e-1)","unprognostic (3.54e-2)","unprognostic (3.58e-1)","unprognostic (4.73e-1)","unprognostic (2.36e-1)","prognostic unfavorable (1.98e-4)","prognostic favorable (1.35e-6)","unprognostic (4.68e-2)","unprognostic (6.33e-2)","prognostic favorable (4.99e-4)","unprognostic (1.21e-2)",9,2,2,13,"ENST00000490286",1,0,"Adipose; Blood.Vessel; Muscle",NA
"ECM1","","ENSG00000143369","Extracellular matrix protein 1","Q16610","1","150508062-150513789","Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins","Angiogenesis, Biomineralization, Mineral balance, Osteogenesis","","Disease variant","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"epididymis: 484.1;esophagus: 1370.5","Cell type enhanced","Detected in many",NA,"Endometrial stromal cells: 107.5;Fibroblasts: 105.1;Melanocytes: 92.3;Suprabasal keratinocytes: 134.2","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"skin cancer: 171.3","Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Heart muscle - Fibroblasts, Liver - Hepatic stellate cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Keratinocyte (granular), Stomach - Fibroblasts, Thyroid - Fibroblasts","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA027241, HPA076029","Enhanced","","Approved","Nucleoplasm,Cytosol","Secreted to extracellular matrix",NA,NA,NA,8.7e+09,"Cluster 25: Monocytes - Inflammatory response","Cluster 84: Esophagus - Epithelial cell function","Cluster 40: Non-specific - Enzymes","Cluster 3: Suprabasal keratinocytes - Cornification","Cytosol","Nucleoplasm","HPA027241: AB_1847976, HPA076029: ","unprognostic (2.89e-2)","unprognostic (1.17e-1)","unprognostic (2.11e-1)","unprognostic (1.13e-2)","unprognostic (1.09e-1)","unprognostic (6.79e-3)","unprognostic (8.42e-2)","unprognostic (2.15e-2)","unprognostic (4.90e-2)","unprognostic (7.50e-2)","prognostic unfavorable (3.55e-4)","unprognostic (5.33e-2)","prognostic unfavorable (1.51e-9)","unprognostic (1.23e-2)","unprognostic (1.92e-1)","unprognostic (1.36e-1)","prognostic unfavorable (1.20e-5)",7,0,7,14,"ENST00000369049",0,0,"Blood.Vessel",NA
"EDIL3","DEL1","ENSG00000164176","EGF like repeats and discoidin domains 3","O43854","5","83940554-84384880","Predicted secreted proteins","Cell adhesion","Developmental protein","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in many",6,"brain: 256.8","Group enriched","Detected in many",5,"Oligodendrocyte precursor cells: 537.7;Oligodendrocytes: 2001.0","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Brain cancer: 123.7;Kidney cancer: 125.1","Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Prostate - Fibroblasts","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA020415, HPA022122","Approved","","Uncertain","Plasma membrane","Secreted to blood",NA,NA,NA,NA,"","Cluster 70: Brain - Nervous system development","Cluster 20: Connective tissue cells - ECM organization","Cluster 8: Oligodendrocytes - Myelin sheath organization","Plasma membrane","","HPA020415: AB_2670434, HPA022122: ","unprognostic (9.93e-3)","unprognostic (2.38e-1)","unprognostic (2.71e-2)","unprognostic (8.63e-2)","unprognostic (2.22e-1)","unprognostic (1.01e-1)","unprognostic (1.16e-2)","unprognostic (9.19e-2)","unprognostic (6.64e-3)","unprognostic (2.98e-1)","unprognostic (1.56e-1)","unprognostic (1.04e-1)","unprognostic (1.03e-3)","unprognostic (2.52e-2)","unprognostic (1.05e-1)","unprognostic (1.52e-2)","unprognostic (1.28e-3)",8,0,9,17,NA,1,0,"Heart; Muscle",NA
"FBLN2","","ENSG00000163520","Fibulin 2","P98095","3","13549125-13638422","Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"heart muscle: 292.8","Cell type enhanced","Detected in many",NA,"Adipocytes: 88.4;Endometrial stromal cells: 85.2;Fibroblasts: 411.5;Leydig cells: 178.2;Peritubular cells: 218.7","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Immune cell enhanced","Detected in some",NA,"myeloid DC: 6.7;naive CD8 T-cell: 3.7","Low lineage specificity","Detected in many",NA,"","Low cancer specificity","Detected in many",NA,"","Heart muscle - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Pancreas - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_2","Group enriched","Detected in many",4,"olfactory bulb: 12.4;white matter: 3.1","Low region specificity","Detected in all",NA,"","HPA001934, CAB018622","Enhanced","","Supported","Plasma membrane","Secreted to extracellular matrix",NA,NA,NA,3.5e+07,"Cluster 28: Myeloid DCs - Unknown function","Cluster 82: Adipose tissue - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 65: Fibroblasts - ECM organization","Plasma membrane","","CAB018622: AB_2294196, HPA001934: AB_1078827","unprognostic (1.19e-1)","unprognostic (7.76e-2)","unprognostic (3.21e-1)","prognostic unfavorable (9.48e-4)","unprognostic (2.82e-2)","unprognostic (1.05e-1)","prognostic favorable (3.17e-4)","unprognostic (8.02e-2)","unprognostic (1.72e-1)","unprognostic (1.70e-2)","unprognostic (2.57e-1)","unprognostic (4.66e-2)","unprognostic (2.13e-2)","unprognostic (1.89e-2)","unprognostic (2.82e-2)","unprognostic (2.61e-2)","unprognostic (1.41e-1)",5,0,5,10,NA,0,0,"Heart; Muscle","Idiopathic.Pulmonary.Fibrosis"
"FBN1","FBN, MASS, MFS1, OCTD, SGS, WMS","ENSG00000166147","Fibrillin 1","P35555","15","48408313-48645721","Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins","","Heparin-binding, Hormone","Aortic aneurysm, Disease variant, Dwarfism","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"adipose tissue: 60.9;placenta: 76.7","Cell type enhanced","Detected in many",NA,"Cytotrophoblasts: 128.7;Fibroblasts: 429.8;Inhibitory neurons: 120.7;Leydig cells: 240.1;Oligodendrocytes: 206.4;Peritubular cells: 231.7","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Brain cancer: 81.0;thyroid cancer: 77.9","Adipose subcutaneous - Adipose progenitor cells, Colon - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts, Skin - Fibroblast_2","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","CAB002670, HPA017759, HPA021057, CAB058696, CAB068188","Enhanced","","Approved","Golgi apparatus,Plasma membrane","Secreted to blood",NA,NA,NA,5.2e+08,"","Cluster 82: Adipose tissue - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 65: Fibroblasts - ECM organization","Golgi apparatus","Plasma membrane","CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586","unprognostic (3.97e-2)","unprognostic (1.55e-2)","unprognostic (2.40e-2)","unprognostic (9.50e-2)","unprognostic (1.51e-1)","unprognostic (9.49e-2)","unprognostic (2.00e-2)","unprognostic (4.79e-2)","unprognostic (7.82e-2)","unprognostic (1.50e-2)","unprognostic (2.78e-2)","unprognostic (1.14e-1)","prognostic unfavorable (7.44e-5)","prognostic unfavorable (6.57e-4)","unprognostic (1.25e-2)","unprognostic (8.69e-3)","prognostic unfavorable (5.11e-4)",5,0,12,17,"ENST00000537463",0,0,NA,"Idiopathic.Pulmonary.Fibrosis"
"FBN2","CCA, DA9","ENSG00000138829","Fibrillin 2","P35556","5","128257909-128659185","Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","","Cancer-related genes, Disease variant","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in some",11,"placenta: 81.9","Group enriched","Detected in many",4,"Cytotrophoblasts: 295.8;Syncytiotrophoblasts: 156.5","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in some",NA,"","Immune cell enhanced","Detected in single",NA,"non-classical monocyte: 2.2","Lineage enriched","Detected in single",5,"monocytes: 2.2","Cancer enhanced","Detected in many",NA,"Sarcoma: 51.2;testis cancer: 48.0","Testis - Early spermatids","Region enhanced","Detected in single",NA,"olfactory bulb: 2.0","Low region specificity","Detected in many",NA,"","HPA012853, CAB026401","Enhanced","","","","Secreted to extracellular matrix",NA,NA,NA,1.1e+07,"Cluster 14: Monocytes - Unknown function","Cluster 28: Placenta - Pregnancy","Cluster 34: Rabdoid cancer - Embryonic development","Cluster 28: Cytotrophoblasts - Unknown function","","","CAB026401: , HPA012853: AB_1848588","unprognostic (2.49e-1)","unprognostic (1.14e-1)","unprognostic (7.29e-3)","unprognostic (1.79e-3)","unprognostic (6.74e-2)","unprognostic (2.33e-1)","unprognostic (4.92e-3)","unprognostic (9.41e-2)","unprognostic (1.06e-2)","unprognostic (4.66e-1)","unprognostic (1.12e-1)","unprognostic (8.69e-2)","unprognostic (8.60e-5)","unprognostic (1.04e-2)","unprognostic (3.19e-2)","unprognostic (1.00e-1)","prognostic unfavorable (7.41e-5)",4,10,11,25,NA,0,0,"Thyroid",NA
"FGF5","","ENSG00000138675","Fibroblast growth factor 5","P12034","4","80266599-80336680","Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins","","Growth factor, Mitogen","Disease variant, Proto-oncogene","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Group enriched","Detected in some",5,"brain: 11.7;gallbladder: 3.4","Cell type enhanced","Detected in some",NA,"Excitatory neurons: 9.3;Exocrine glandular cells: 4.3;Melanocytes: 1.7;Microglial cells: 1.8;Proximal tubular cells: 3.9","Not detected","Not detected",NA,"","Region enhanced","Detected in many",NA,"cerebellum: 11.7","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"thyroid cancer: 22.5","Kidney - Proximal tubular cells","Low region specificity","Detected in some",NA,"","Not detected","Not detected",NA,"","","","","","","Secreted in brain",NA,NA,NA,NA,"","Cluster 69: Cerebellum - Gene expression regulation","Cluster 20: Connective tissue cells - ECM organization","Cluster 38: Neurons - Neuronal signaling","","","","unprognostic (6.44e-2)","unprognostic (6.24e-3)","unprognostic (8.49e-4)","unprognostic (1.10e-1)","unprognostic (2.91e-1)","unprognostic (2.80e-3)","","unprognostic (6.87e-4)","unprognostic (2.53e-1)","unprognostic (1.69e-1)","unprognostic (3.57e-3)","unprognostic (1.17e-2)","unprognostic (3.33e-16)","unprognostic (3.02e-3)","unprognostic (3.14e-1)","","unprognostic (2.83e-2)",11,12,12,35,"ENST00000312465; ENST00000456523; ENST00000503413",0,0,"Nerve",NA
"FN1","CIG, FINC, GFND2, LETS, MSF","ENSG00000115414","Fibronectin 1","P02751","2","215360440-215436073","Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Acute phase, Angiogenesis, Cell adhesion, Cell shape","Heparin-binding","Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"liver: 1725.9;placenta: 2928.1","Cell type enhanced","Detected in many",NA,"Extravillous trophoblasts: 3183.4;Fibroblasts: 713.4;Hepatocytes: 809.9;Pancreatic endocrine cells: 523.8;Smooth muscle cells: 552.4","Cancer enhanced","Detected in all",NA,"thyroid cancer: 833.9","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"testis cancer: 4649.5;thyroid cancer: 4327.2","Adipose subcutaneous - Adipose progenitor cells, Breast - Fibroblasts, Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Fibroblasts, Skin - Fibroblast_2","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","CAB000126, HPA027066","Enhanced","","","","Secreted to blood",NA,NA,2.27e+14,4.7e+10,"","Cluster 86: Liver & Placenta - Transport via ER","Cluster 20: Connective tissue cells - ECM organization","Cluster 15: Smooth muscle cells - Muscle contraction","","","CAB000126: , HPA027066: AB_10602500","unprognostic (8.08e-2)","unprognostic (1.09e-3)","unprognostic (2.20e-2)","unprognostic (3.45e-3)","unprognostic (1.82e-2)","unprognostic (3.47e-3)","unprognostic (3.36e-2)","unprognostic (5.91e-3)","unprognostic (2.96e-2)","unprognostic (2.91e-3)","unprognostic (1.41e-2)","unprognostic (2.84e-1)","prognostic unfavorable (3.44e-8)","prognostic unfavorable (8.82e-5)","unprognostic (7.88e-2)","unprognostic (7.74e-2)","prognostic unfavorable (3.33e-4)",5,0,12,17,"ENST00000354785; ENST00000356005; ENST00000426059; ENST00000432072; ENST00000443816; ENST00000446046",1,0,NA,NA
"FST","FS","ENSG00000134363","Follistatin","P19883","5","53480626-53487134","Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","","Cancer-related genes","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"liver: 68.7","Group enriched","Detected in many",6,"Granulosa cells: 676.3;Skeletal myocytes: 213.8","Cancer enhanced","Detected in all",NA,"liver cancer: 45.1","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Gallbladder cancer: 403.5","Heart muscle - Fibroblasts, Kidney - Fibroblasts","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in single",NA,"","HPA016612, CAB026025","Approved","","Approved","Vesicles","Secreted to blood",NA,NA,NA,1800000,"Cluster 32: T-cells - Unknown function","Cluster 85: Liver - Metabolism","Cluster 20: Connective tissue cells - ECM organization","Cluster 17: Granulosa cells - Transcription regulation","Vesicles","","CAB026025: , HPA016612: ","unprognostic (1.43e-1)","unprognostic (6.50e-2)","unprognostic (1.44e-1)","unprognostic (7.73e-3)","unprognostic (2.30e-1)","unprognostic (1.50e-3)","unprognostic (8.02e-2)","unprognostic (2.32e-2)","unprognostic (3.06e-1)","unprognostic (1.57e-1)","unprognostic (1.93e-1)","unprognostic (1.94e-1)","prognostic unfavorable (4.44e-5)","unprognostic (1.21e-3)","unprognostic (2.48e-1)","unprognostic (2.07e-2)","unprognostic (2.18e-1)",5,0,7,12,NA,0,0,"Blood.Vessel; Lung; Muscle",NA
"GDF6","BMP13, KFS, KFS1, SGM1","ENSG00000156466","Growth differentiation factor 6","Q6KF10","8","96142333-96160806","Disease related genes, Human disease related genes, Predicted secreted proteins","Apoptosis","Cytokine, Developmental protein, Growth factor","Deafness, Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia, Non-syndromic deafness","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in some",NA,"placenta: 10.9","Cell type enhanced","Detected in some",NA,"Basal prostatic cells: 1.5;Cardiomyocytes: 2.4;Distal tubular cells: 3.1;Excitatory neurons: 1.6;Fibroblasts: 2.2;Oligodendrocyte precursor cells: 6.7;Pancreatic endocrine cells: 1.7;Spermatogonia: 2.2;Thymic epithelial cells: 2.8","Cancer enhanced","Detected in some",NA,"renal cancer: 2.8;thyroid cancer: 2.3","Low region specificity","Detected in single",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in some",NA,"Bone cancer: 32.6;testis cancer: 15.9","Breast - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Thyroid - Fibroblasts","Not detected","Not detected",NA,"","Region enriched","Detected in single",5,"midbrain: 1.2","HPA045206","Uncertain","","Supported","Nucleoplasm,Nuclear membrane,Vesicles","Secreted to blood",NA,NA,NA,NA,"","Cluster 28: Placenta - Pregnancy","Cluster 14: Bone cancer - Transcription","Cluster 53: Connective tissue cells - ECM organization","Vesicles","Nucleoplasm, Nuclear membrane","HPA045206: AB_10962508","unprognostic (1.13e-1)","unprognostic (1.60e-1)","unprognostic (1.83e-2)","unprognostic (9.66e-9)","unprognostic (6.49e-2)","unprognostic (1.47e-1)","unprognostic (1.41e-1)","unprognostic (3.18e-2)","unprognostic (3.80e-3)","unprognostic (1.09e-3)","unprognostic (5.37e-2)","unprognostic (8.13e-3)","prognostic unfavorable (2.17e-4)","unprognostic (5.88e-4)","unprognostic (1.88e-2)","unprognostic (2.68e-2)","unprognostic (1.71e-1)",4,4,3,11,NA,0,0,"Adipose; Heart",NA
"GREM1","CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS","ENSG00000166923","Gremlin 1, DAN family BMP antagonist","O60565","15","32718004-32745106","Disease related genes, Predicted secreted proteins","","Cytokine","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"gallbladder: 113.0;smooth muscle: 68.2","Cell type enhanced","Detected in many",NA,"Cardiomyocytes: 366.9;Collecting duct cells: 65.0;Granulosa cells: 119.2","Cancer enhanced","Detected in many",NA,"stomach cancer: 24.6","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Sarcoma: 31.2;thyroid cancer: 32.1","Testis - Spermatogonia","Group enriched","Detected in many",5,"hippocampal formation: 3.2;olfactory bulb: 10.9","Low region specificity","Detected in many",NA,"","HPA007526","Uncertain","","","","Secreted to blood",NA,NA,2.42e+08,NA,"","Cluster 12: Smooth muscle tissue - Mixed function","Cluster 20: Connective tissue cells - ECM organization","Cluster 77: Cardiomyocytes - Muscle contraction","","","HPA007526: AB_1849971","unprognostic (4.74e-2)","unprognostic (2.78e-1)","unprognostic (4.63e-2)","unprognostic (6.80e-2)","unprognostic (3.58e-1)","unprognostic (1.72e-1)","unprognostic (3.19e-1)","prognostic unfavorable (4.46e-4)","unprognostic (5.33e-2)","unprognostic (2.32e-1)","unprognostic (7.20e-3)","unprognostic (2.79e-1)","unprognostic (2.13e-11)","unprognostic (1.77e-2)","unprognostic (6.60e-2)","unprognostic (3.29e-2)","unprognostic (1.16e-3)",10,3,12,25,"ENST00000300177",0,0,"Blood.Vessel","Idiopathic.Pulmonary.Fibrosis"
"HLA-G","","ENSG00000204632","Major histocompatibility complex, class I, G","P17693","6","29826967-29831125","Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins","Immunity","","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Group enriched","Detected in some",5,"pituitary gland: 13.8;placenta: 11.1","Cell type enriched","Detected in many",21,"Extravillous trophoblasts: 2193.5","Low cancer specificity","Detected in all",NA,"","Not detected","Not detected",NA,"","Low immune cell specificity","Detected in many",NA,"","Low lineage specificity","Detected in many",NA,"","Cancer enhanced","Detected in single",NA,"lung cancer: 1.5","Testis - Late spermatids","","",NA,"","","",NA,"","CAB016158","Enhanced","","","","Secreted to blood",NA,NA,32800000,6.7e+07,"Cluster 5: Granulocytes - Unknown function","Cluster 28: Placenta - Pregnancy","Cluster 46: Non-specific - Unknown function","Cluster 54: Extravillous trophoblasts - Unknown function","","","CAB016158: AB_627938","unprognostic (1.13e-2)","unprognostic (9.95e-2)","unprognostic (1.30e-1)","unprognostic (3.40e-2)","unprognostic (8.35e-2)","unprognostic (1.35e-1)","unprognostic (1.18e-3)","unprognostic (2.51e-1)","prognostic favorable (3.91e-5)","unprognostic (6.34e-2)","unprognostic (8.31e-2)","unprognostic (1.78e-1)","unprognostic (1.03e-2)","unprognostic (6.56e-3)","unprognostic (1.40e-1)","unprognostic (1.52e-2)","unprognostic (3.19e-3)",8,4,0,12,NA,0,0,NA,NA
"IGFBP3","BP-53, IBP3","ENSG00000146674","Insulin like growth factor binding protein 3","P17936","7","45912245-45921874","Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Apoptosis","Growth factor binding","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"placenta: 1864.4","Cell type enhanced","Detected in many",NA,"Basal respiratory cells: 827.6;Club cells: 413.8;Extravillous trophoblasts: 2466.4;Ionocytes: 432.6","Cancer enhanced","Detected in all",NA,"renal cancer: 377.7","Low region specificity","Detected in all",NA,"","Immune cell enriched","Detected in many",5,"plasmacytoid DC: 54.5","Lineage enriched","Detected in many",5,"dendritic cells: 54.5","Cancer enhanced","Detected in all",NA,"Kidney cancer: 3126.4","Liver - Hepatic stellate cells, Testis - Endothelial cells","Low region specificity","Detected in all",NA,"","","",NA,"","CAB010360","","","Uncertain","Vesicles","Secreted to blood",NA,NA,3.25e+09,3.6e+09,"Cluster 3: Plasmacytoid DCs - Unknown function","Cluster 86: Liver & Placenta - Transport via ER","Cluster 68: Kidney - Mixed function","Cluster 53: Connective tissue cells - ECM organization","Vesicles","","CAB010360: AB_2233528","unprognostic (4.46e-3)","unprognostic (4.84e-2)","prognostic unfavorable (1.08e-4)","unprognostic (2.30e-1)","unprognostic (1.15e-1)","unprognostic (6.54e-2)","prognostic unfavorable (1.64e-4)","unprognostic (8.14e-3)","unprognostic (3.31e-2)","unprognostic (2.03e-1)","unprognostic (9.67e-3)","unprognostic (2.80e-1)","prognostic unfavorable (5.07e-7)","unprognostic (2.36e-2)","unprognostic (4.14e-2)","unprognostic (2.37e-3)","unprognostic (2.63e-1)",6,0,6,12,NA,1,1,"Colon; Heart; Lung","Heart.Failure"
"IGFBP5","","ENSG00000115461","Insulin like growth factor binding protein 5","P24593","2","216672105-216695549","Plasma proteins, Predicted secreted proteins","","Growth factor binding","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 1492.5;ovary: 1323.4","Cell type enhanced","Detected in many",NA,"Fibroblasts: 1239.4;Leydig cells: 1826.4;Muller glia cells: 615.9;Peritubular cells: 1001.5;Sertoli cells: 616.4;Smooth muscle cells: 1293.2","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Brain cancer: 341.6;breast cancer: 389.0","Pancreas - Fibroblasts, Skin - Fibroblast_2","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA040514, HPA070407","","Supported","Approved","Vesicles","Secreted to blood",NA,NA,1.1e+08,3.8e+08,"","Cluster 89: Fibroblasts - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 72: Smooth muscle cells - ECM organization","Vesicles","","HPA040514: AB_2677016, HPA070407: ","unprognostic (7.69e-2)","unprognostic (2.56e-1)","unprognostic (1.02e-1)","prognostic unfavorable (1.78e-4)","unprognostic (4.58e-2)","unprognostic (3.47e-1)","unprognostic (2.04e-1)","unprognostic (1.76e-1)","unprognostic (1.32e-1)","unprognostic (9.58e-2)","unprognostic (1.12e-1)","unprognostic (2.41e-2)","unprognostic (4.04e-2)","unprognostic (9.62e-3)","unprognostic (1.55e-1)","unprognostic (3.28e-2)","unprognostic (1.91e-3)",11,0,11,22,NA,1,1,NA,"Idiopathic.Pulmonary.Fibrosis"
"IL12A","CLMF, IL-12A, NFSK, NKSF1, p35","ENSG00000168811","Interleukin 12A","P29459","3","159988835-159996019","Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins","Host-virus interaction","Cytokine, Growth factor","Cancer-related genes","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in some",NA,"esophagus: 4.1","Cell type enhanced","Detected in some",NA,"Endometrial ciliated cells: 3.6;Oligodendrocyte precursor cells: 3.9;Plasma cells: 3.3;Respiratory ciliated cells: 2.9;Schwann cells: 4.0","Low cancer specificity","Detected in some",NA,"","Low region specificity","Detected in many",NA,"","Immune cell enhanced","Detected in single",NA,"naive B-cell: 2.2","Low lineage specificity","Detected in single",NA,"","Low cancer specificity","Detected in many",NA,"","","Region enhanced","Detected in single",NA,"cerebral cortex: 2.8","Not detected","Not detected",NA,"","HPA001886","Uncertain","","","","Secreted to blood",NA,NA,NA,NA,"Cluster 19: B-cells - Humoral immune response","Cluster 27: Brain & Skin - Unknown function","Cluster 20: Connective tissue cells - ECM organization","Cluster 32: Neurons - Synaptic function","","","HPA001886: AB_1079132","unprognostic (6.23e-2)","unprognostic (7.82e-5)","unprognostic (1.25e-1)","unprognostic (3.10e-2)","unprognostic (4.22e-1)","unprognostic (7.18e-2)","unprognostic (4.18e-5)","unprognostic (2.22e-1)","unprognostic (1.91e-1)","unprognostic (1.07e-2)","unprognostic (1.28e-1)","unprognostic (2.31e-2)","unprognostic (9.57e-10)","unprognostic (1.62e-1)","unprognostic (1.42e-1)","unprognostic (1.16e-1)","unprognostic (9.61e-2)",5,5,1,11,NA,0,0,NA,NA
"IL6","BSF2, HGF, HSF, IFNB2, IL-6","ENSG00000136244","Interleukin 6","P05231","7","22725884-22732002","Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Acute phase","Cytokine, Growth factor","Cancer-related genes, FDA approved drug targets","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"adipose tissue: 217.6;urinary bladder: 281.3","Cell type enhanced","Detected in many",NA,"Adipocytes: 184.9;Endometrial ciliated cells: 142.3;Endothelial cells: 211.0;Glandular and luminal cells: 333.0;Smooth muscle cells: 283.8","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","Group enriched","Detected in some",44,"memory B-cell: 3.9;naive B-cell: 4.8","Lineage enriched","Detected in single",48,"B-cells: 4.8","Cancer enhanced","Detected in many",NA,"Kidney cancer: 233.7","Colon - Neutrophils","Not detected","Not detected",NA,"","Low region specificity","Detected in many",NA,"","CAB023406, CAB072821","Supported","","Approved","Vesicles","Secreted to blood",NA,NA,5700,NA,"Cluster 21: B-cells - Adaptive immune response","Cluster 82: Adipose tissue - ECM organization","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 72: Smooth muscle cells - ECM organization","Vesicles","","CAB023406: AB_617317, CAB072821: ","unprognostic (1.13e-1)","unprognostic (1.55e-2)","unprognostic (1.47e-1)","unprognostic (1.35e-1)","unprognostic (3.59e-2)","unprognostic (9.88e-3)","unprognostic (1.35e-1)","unprognostic (3.07e-3)","unprognostic (3.25e-1)","unprognostic (2.17e-1)","unprognostic (2.48e-2)","unprognostic (8.57e-2)","prognostic unfavorable (1.10e-11)","unprognostic (2.45e-3)","unprognostic (2.10e-1)","unprognostic (4.31e-2)","unprognostic (7.80e-2)",7,3,0,10,NA,0,1,"Brain",NA
"INHBA","","ENSG00000122641","Inhibin subunit beta A","P08476","7","41667168-41705834","Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins","","Growth factor, Hormone","Cancer-related genes","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"gallbladder: 21.6","Cell type enhanced","Detected in many",NA,"Fibroblasts: 98.4;Granulosa cells: 101.9;Langerhans cells: 90.3;Leydig cells: 151.7;Pancreatic endocrine cells: 340.1;Syncytiotrophoblasts: 180.4","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"thyroid cancer: 137.5","Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Fibroblasts, Skeletal muscle - Fibroblasts","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","","","","","","Secreted to blood",NA,NA,NA,210000,"","Cluster 85: Liver - Metabolism","Cluster 20: Connective tissue cells - ECM organization","Cluster 19: Macrophages - Innate immune response","","","","unprognostic (4.11e-3)","prognostic unfavorable (1.46e-5)","unprognostic (4.22e-2)","unprognostic (1.08e-1)","unprognostic (5.18e-2)","prognostic unfavorable (4.34e-4)","unprognostic (2.05e-2)","prognostic unfavorable (7.72e-4)","unprognostic (1.44e-1)","unprognostic (1.31e-1)","unprognostic (1.23e-2)","unprognostic (2.04e-1)","prognostic unfavorable (7.91e-8)","unprognostic (6.22e-3)","unprognostic (1.11e-2)","unprognostic (3.25e-2)","unprognostic (3.18e-3)",4,5,4,13,NA,0,0,NA,NA
"KISS1","","ENSG00000170498","KiSS-1 metastasis suppressor","Q15726","1","204190341-204196491","Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins","","","Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in some",22,"placenta: 233.1","Cell type enriched","Detected in many",31,"Syncytiotrophoblasts: 1384.1","Cancer enhanced","Detected in many",NA,"urothelial cancer: 9.2","Region enriched","Detected in some",6,"hypothalamus: 10.7","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","Lung - Alveolar cells type 2, Testis - Late spermatids","","",NA,"","Not detected","Not detected",NA,"","CAB017775, HPA035542","Enhanced","","Approved","Vesicles","Secreted in female reproductive system",NA,NA,NA,860000,"","Cluster 28: Placenta - Pregnancy","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 67: Syncytiotrophoblasts - Pregnancy","Vesicles","","CAB017775: , HPA035542: AB_2674677","unprognostic (9.64e-2)","unprognostic (1.78e-2)","unprognostic (1.86e-2)","unprognostic (1.18e-2)","unprognostic (3.89e-1)","unprognostic (6.87e-2)","unprognostic (1.87e-1)","unprognostic (3.28e-2)","","unprognostic (1.28e-2)","unprognostic (4.51e-2)","unprognostic (1.63e-1)","unprognostic (8.98e-12)","unprognostic (2.25e-1)","unprognostic (2.91e-2)","unprognostic (1.76e-1)","prognostic favorable (6.29e-6)",6,7,3,16,NA,0,0,NA,NA
"LAMA1","LAMA","ENSG00000101680","Laminin subunit alpha 1","P25391","18","6941742-7117797","Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion","","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in some",NA,"testis: 5.9","Group enriched","Detected in many",4,"Astrocytes: 87.9;Distal enterocytes: 132.4;Granulosa cells: 75.6;Intestinal goblet cells: 40.1;Paneth cells: 38.9;Proximal enterocytes: 45.1","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"skin cancer: 36.7","Skin - Eccrine sweat gland cells, Testis - Sertoli cells","Low region specificity","Detected in single",NA,"","Low region specificity","Detected in many",NA,"","CAB010179","Enhanced","","","","Secreted to extracellular matrix",NA,NA,NA,NA,"","Cluster 43: Testis - Unknown function","Cluster 16: Skin cancer - Melanocyte processes","Cluster 50: Enterocytes - Absorption","","","CAB010179: AB_2133741","unprognostic (2.75e-1)","unprognostic (3.66e-4)","unprognostic (2.08e-1)","unprognostic (3.56e-1)","unprognostic (4.97e-3)","unprognostic (3.66e-2)","unprognostic (1.72e-2)","unprognostic (7.94e-2)","unprognostic (2.23e-2)","unprognostic (3.43e-2)","unprognostic (3.02e-1)","unprognostic (6.80e-2)","unprognostic (1.92e-1)","unprognostic (1.78e-2)","unprognostic (4.85e-1)","unprognostic (3.47e-2)","unprognostic (7.34e-3)",2,2,6,10,"ENST00000579014",0,0,NA,NA
"LAMC1","LAMB2","ENSG00000135862","Laminin subunit gamma 1","P11047","1","183023420-183145592","Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion","","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"placenta: 231.7","Cell type enhanced","Detected in many",NA,"Fibroblasts: 217.5","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"testis cancer: 459.0","","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA001908, HPA001909, CAB004486, CAB078163","Enhanced","","Approved","Endoplasmic reticulum,Plasma membrane","Secreted to extracellular matrix",NA,NA,NA,1e+08,"Cluster 37: B-cells - Transcription","Cluster 82: Adipose tissue - ECM organization","Cluster 59: Fibroblasts - Metabolism","Cluster 65: Fibroblasts - ECM organization","Endoplasmic reticulum, Plasma membrane","","CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230","unprognostic (1.46e-1)","unprognostic (1.05e-2)","unprognostic (8.30e-2)","unprognostic (8.84e-3)","unprognostic (3.75e-2)","unprognostic (1.02e-1)","unprognostic (1.55e-2)","unprognostic (1.54e-2)","unprognostic (1.38e-2)","unprognostic (2.71e-2)","unprognostic (1.10e-1)","unprognostic (1.80e-1)","unprognostic (1.88e-3)","unprognostic (1.10e-3)","unprognostic (1.53e-1)","unprognostic (1.54e-1)","prognostic unfavorable (8.85e-5)",0,0,11,11,"ENST00000478064; ENST00000479499",1,0,NA,NA
"LIF","CDF, DIA, HILDA","ENSG00000128342","LIF interleukin 6 family cytokine","P15018","22","30240453-30246759","Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","Cytokine, Growth factor","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"gallbladder: 47.7;urinary bladder: 91.0","Cell type enhanced","Detected in many",NA,"Basal respiratory cells: 98.6;Endometrial ciliated cells: 69.3;Glandular and luminal cells: 180.4;granulocytes: 116.9;Ionocytes: 283.1","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","Pancreas - Ductal cells","Not detected","Not detected",NA,"","Not detected","Not detected",NA,"","HPA018844, CAB025985","Uncertain","","Supported","Cytosol","Secreted in other tissues",NA,NA,NA,NA,"","Cluster 82: Adipose tissue - ECM organization","Cluster 33: Skin cancer - Membrane components","Cluster 14: Endometrium - Transcription regulation","Cytosol","","CAB025985: , HPA018844: AB_1852814","unprognostic (1.28e-2)","prognostic unfavorable (9.01e-4)","unprognostic (8.79e-2)","unprognostic (4.61e-2)","unprognostic (7.36e-3)","unprognostic (4.18e-3)","unprognostic (1.17e-2)","unprognostic (1.41e-2)","unprognostic (3.18e-3)","unprognostic (1.22e-1)","unprognostic (8.10e-2)","unprognostic (9.65e-2)","prognostic unfavorable (6.78e-8)","unprognostic (2.02e-1)","unprognostic (6.40e-2)","unprognostic (8.99e-2)","unprognostic (4.71e-3)",7,6,6,19,NA,0,0,"Adrenal.Gland",NA
"LOX","","ENSG00000113083","Lysyl oxidase","P28300","5","122063195-122078413","Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins","","Oxidoreductase","Aortic aneurysm, Disease variant","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"adipose tissue: 27.9","Cell type enhanced","Detected in many",NA,"Basal respiratory cells: 64.4;Early spermatids: 45.5;Extravillous trophoblasts: 49.0;Fibroblasts: 84.1;Pancreatic endocrine cells: 125.4;Thymic epithelial cells: 58.0","Cancer enhanced","Detected in all",NA,"renal cancer: 39.8","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Brain cancer: 82.3","Heart muscle - Fibroblasts, Skin - Fibroblast_2","Low region specificity","Detected in some",NA,"","Low region specificity","Detected in many",NA,"","HPA043930","","","Approved","Endoplasmic reticulum","Secreted to extracellular matrix",NA,NA,NA,550000,"","Cluster 82: Adipose tissue - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Endoplasmic reticulum","","HPA043930: AB_2678736","unprognostic (5.10e-2)","unprognostic (1.03e-2)","unprognostic (6.99e-3)","unprognostic (3.64e-2)","unprognostic (9.86e-3)","unprognostic (1.91e-1)","prognostic unfavorable (7.38e-4)","unprognostic (2.42e-3)","unprognostic (3.06e-3)","unprognostic (8.92e-2)","unprognostic (3.21e-3)","unprognostic (1.91e-1)","prognostic unfavorable (3.93e-8)","unprognostic (1.11e-3)","unprognostic (9.92e-2)","unprognostic (4.31e-2)","prognostic unfavorable (3.32e-4)",9,6,12,27,"ENST00000231004; ENST00000503759; ENST00000505593; ENST00000508067; ENST00000513319",1,0,"Lung; Muscle",NA
"LOXL2","LOR, WS9-14","ENSG00000134013","Lysyl oxidase like 2","Q9Y4K0","8","23296897-23425328","Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins","Transcription, Transcription regulation","Chromatin regulator, Oxidoreductase, Repressor","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"smooth muscle: 41.3","Cell type enhanced","Detected in many",NA,"Basal respiratory cells: 23.1;Endometrial stromal cells: 26.0;Endothelial cells: 28.1;Extravillous trophoblasts: 25.3;Fibroblasts: 38.8;Pancreatic endocrine cells: 37.8;Smooth muscle cells: 20.1","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"Kidney cancer: 598.7","Breast - Adipocytes (Breast), Skeletal muscle - Fibroblasts, Thyroid - Endothelial cells","Low region specificity","Detected in single",NA,"","Low region specificity","Detected in single",NA,"","CAB025848, HPA036257, HPA056542","Approved","","Enhanced","Nucleoplasm","Secreted to extracellular matrix",NA,NA,NA,NA,"Cluster 49: Eosinophils - Unknown function","Cluster 46: Fibroblasts - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Nucleoplasm","","CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168","unprognostic (9.48e-2)","prognostic unfavorable (9.83e-6)","unprognostic (2.03e-1)","unprognostic (2.81e-2)","prognostic unfavorable (1.24e-4)","unprognostic (5.55e-2)","unprognostic (1.42e-2)","prognostic unfavorable (1.46e-7)","unprognostic (2.91e-2)","unprognostic (3.63e-3)","prognostic unfavorable (9.05e-4)","unprognostic (1.25e-1)","prognostic unfavorable (2.91e-7)","unprognostic (1.51e-2)","unprognostic (7.07e-2)","unprognostic (4.93e-2)","unprognostic (3.68e-3)",7,5,13,25,"ENST00000389131; ENST00000520349",1,0,NA,NA
"LRRC17","H_RG318M05.3, P37NB","ENSG00000128606","Leucine rich repeat containing 17","Q8N6Y2","7","102913000-102945111","Predicted secreted proteins","Osteogenesis","","","Evidence at protein level","Evidence at transcript level","Evidence at transcript level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"ovary: 76.2","Cell type enhanced","Detected in many",NA,"Fibroblasts: 28.2;Granulosa cells: 67.2;Leydig cells: 110.8;Peritubular cells: 34.5;Sertoli cells: 27.6","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","Immune cell enriched","Detected in single",94,"eosinophil: 9.9","Lineage enriched","Detected in single",94,"granulocytes: 9.9","Cancer enhanced","Detected in many",NA,"Brain cancer: 57.1;Sarcoma: 73.1","Liver - Hepatic stellate cells, Lung - Fibroblast_2, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Thyroid - Fibroblasts","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","HPA073458","","","Approved","Vesicles,Cytokinetic bridge","Secreted in other tissues","Yes",NA,NA,NA,"Cluster 45: Eosinophils - Innate immune response","Cluster 89: Fibroblasts - ECM organization","Cluster 42: Sarcoma - Muscle contraction","Cluster 17: Granulosa cells - Transcription regulation","Vesicles","Cytokinetic bridge","HPA073458: ","unprognostic (1.77e-1)","unprognostic (7.73e-2)","unprognostic (4.79e-2)","unprognostic (1.47e-1)","unprognostic (1.03e-1)","unprognostic (2.48e-1)","unprognostic (4.46e-1)","unprognostic (1.18e-1)","unprognostic (9.76e-4)","unprognostic (6.09e-3)","unprognostic (2.26e-1)","unprognostic (2.39e-1)","prognostic unfavorable (4.12e-6)","unprognostic (8.57e-3)","unprognostic (4.48e-2)","unprognostic (6.17e-2)","prognostic unfavorable (6.30e-4)",9,9,9,27,"ENST00000249377; ENST00000339431",0,0,"Blood.Vessel",NA
"LTBP1","","ENSG00000049323","Latent transforming growth factor beta binding protein 1","Q14766","2","32946953-33399509","Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","Growth factor binding","Disease variant","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 161.4","Cell type enhanced","Detected in many",NA,"Astrocytes: 105.0;Cardiomyocytes: 89.9;Fibroblasts: 92.5;Leydig cells: 95.6;Mucus glandular cells: 116.8;Peritubular cells: 162.3;Smooth muscle cells: 111.4","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Immune cell enriched","Detected in single",4,"basophil: 3.1","Lineage enriched","Detected in single",14,"granulocytes: 3.1","Low cancer specificity","Detected in all",NA,"","Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Pancreas - Fibroblasts, Prostate - Smooth muscle cells","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","CAB025428","Approved","","","","Secreted to extracellular matrix",NA,NA,NA,9.6e+07,"Cluster 10: Basophils - Unknown function","Cluster 46: Fibroblasts - ECM organization","Cluster 20: Connective tissue cells - ECM organization","Cluster 15: Smooth muscle cells - Muscle contraction","","","CAB025428: ","unprognostic (1.02e-2)","unprognostic (1.12e-1)","unprognostic (5.29e-2)","unprognostic (6.23e-2)","unprognostic (3.11e-3)","unprognostic (1.83e-1)","unprognostic (1.06e-3)","unprognostic (5.67e-2)","unprognostic (7.48e-2)","unprognostic (1.14e-1)","unprognostic (9.96e-3)","unprognostic (1.05e-1)","prognostic unfavorable (7.79e-6)","unprognostic (4.61e-2)","unprognostic (1.06e-1)","unprognostic (1.91e-1)","prognostic unfavorable (1.62e-4)",8,0,9,17,"ENST00000402934; ENST00000407925; ENST00000422669",0,0,NA,"Idiopathic.Pulmonary.Fibrosis"
"LUM","LDC, SLRR2D","ENSG00000139329","Lumican","P51884","12","91102629-91111494","Cancer-related genes, Plasma proteins, Predicted secreted proteins","","","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"gallbladder: 739.0;placenta: 535.9","Group enriched","Detected in many",10,"Endometrial stromal cells: 990.9;Fibroblasts: 1398.8;Leydig cells: 414.2;Smooth muscle cells: 491.6","Low cancer specificity","Detected in all",NA,"","Region enriched","Detected in some",4,"cerebral cortex: 5.6","Immune cell enriched","Detected in single",122,"basophil: 12.1","Lineage enriched","Detected in single",122,"granulocytes: 12.1","Cancer enhanced","Detected in many",NA,"Rhabdoid: 221.2","Adipose subcutaneous - Adipose progenitor cells, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Stomach - Fibroblasts, Thyroid - Fibroblasts","Low region specificity","Detected in all",NA,"","Region enriched","Detected in all",9,"spinal cord: 149.2","HPA001522, CAB025783","Supported","","","","Secreted to extracellular matrix",NA,NA,NA,2.9e+10,"Cluster 38: Basophils - Unknown function","Cluster 82: Adipose tissue - ECM organization","Cluster 22: Rhabdoid cancers - Neuronal signaling","Cluster 53: Connective tissue cells - ECM organization","","","CAB025783: , HPA001522: AB_1079285","unprognostic (5.54e-2)","unprognostic (2.27e-1)","unprognostic (3.32e-1)","unprognostic (2.75e-1)","unprognostic (1.65e-1)","unprognostic (8.38e-2)","unprognostic (1.09e-1)","unprognostic (2.87e-1)","unprognostic (4.08e-2)","unprognostic (1.19e-1)","unprognostic (1.65e-2)","unprognostic (2.20e-2)","prognostic unfavorable (1.75e-6)","unprognostic (5.25e-3)","unprognostic (2.27e-2)","unprognostic (2.38e-2)","unprognostic (2.06e-2)",8,0,8,16,NA,1,0,"Adipose; Blood.Vessel; Muscle",NA
"MASP1","CRARF, MASP, PRSS5","ENSG00000127241","Mannan binding lectin serine peptidase 1","P48740","3","187217282-187291980","Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins","Complement activation lectin pathway, Immunity, Innate immunity","Hydrolase, Protease, Serine protease","Disease variant","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 120.0;heart muscle: 116.1;liver: 183.4","Cell type enhanced","Detected in some",NA,"Astrocytes: 27.2;Cardiomyocytes: 29.4;Cholangiocytes: 26.9;Endometrial stromal cells: 30.1;Fibroblasts: 17.1;Hepatocytes: 58.1","Group enriched","Detected in some",9,"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in some",NA,"liver cancer: 12.0;Rhabdoid: 14.0","Breast - Fibroblasts, Pancreas - Fibroblasts, Prostate - Smooth muscle cells, Skin - Fibroblast_1, Skin - Fibroblast_2","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA001617, HPA009641","Supported","","Enhanced","Nucleoplasm,Cytosol","Secreted to blood","No",NA,8.67e+09,1.9e+09,"","Cluster 85: Liver - Metabolism","Cluster 20: Connective tissue cells - ECM organization","Cluster 52: Endometrial stromal cells - ECM organization","Nucleoplasm, Cytosol","","HPA001617: AB_1079314, HPA009641: AB_1079313","unprognostic (1.67e-1)","unprognostic (1.02e-2)","unprognostic (1.99e-1)","unprognostic (5.20e-2)","unprognostic (1.02e-2)","unprognostic (1.25e-6)","prognostic favorable (2.20e-4)","unprognostic (9.92e-2)","unprognostic (3.22e-1)","unprognostic (2.29e-1)","unprognostic (4.18e-1)","unprognostic (1.29e-1)","unprognostic (2.82e-3)","unprognostic (3.56e-3)","unprognostic (1.97e-1)","unprognostic (7.85e-2)","unprognostic (4.29e-1)",9,0,9,18,NA,1,0,"Blood.Vessel; Lung",NA
"MMP1","CLG","ENSG00000196611","Matrix metallopeptidase 1","P03956","11","102789401-102798160","Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins","Collagen degradation, Host-virus interaction","Hydrolase, Metalloprotease, Protease","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"gallbladder: 75.7;stomach 1: 47.6;urinary bladder: 52.2","Cell type enhanced","Detected in some",NA,"Basal respiratory cells: 78.6;Cholangiocytes: 32.7;Ductal cells: 106.7;Exocrine glandular cells: 66.2;Gastric mucus-secreting cells: 24.4;Pancreatic endocrine cells: 84.2","Cancer enhanced","Detected in many",NA,"head and neck cancer: 344.2","Region enriched","Detected in single",7,"cerebral cortex: 1.3","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Group enriched","Detected in many",6,"ovarian cancer: 408.7;Sarcoma: 782.4;skin cancer: 588.5;thyroid cancer: 1539.1","Pancreas - Ductal cells","Not detected","Not detected",NA,"","","",NA,"","HPA004920","","","Approved","Vesicles","Secreted to extracellular matrix",NA,NA,7730000,55000,"","Cluster 12: Smooth muscle tissue - Mixed function","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 74: Pancreatic cells - Mixed function","Vesicles","","HPA004920: AB_2667293","unprognostic (4.11e-3)","prognostic unfavorable (4.66e-4)","unprognostic (4.20e-3)","unprognostic (1.19e-3)","unprognostic (6.46e-2)","unprognostic (6.50e-2)","prognostic unfavorable (4.22e-6)","unprognostic (7.83e-3)","unprognostic (2.94e-2)","unprognostic (5.44e-2)","unprognostic (1.11e-3)","unprognostic (1.75e-1)","prognostic unfavorable (9.86e-10)","unprognostic (1.67e-2)","unprognostic (1.49e-1)","unprognostic (1.26e-2)","unprognostic (5.11e-2)",12,13,8,33,"ENST00000315274",0,1,NA,"Idiopathic.Pulmonary.Fibrosis"
"MMP2","CLG4, CLG4A, TBE-1","ENSG00000087245","Matrix metallopeptidase 2","P08253","16","55389700-55506691","Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins","Angiogenesis, Collagen degradation","Hydrolase, Metalloprotease, Protease","Cancer-related genes, Disease variant","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"gallbladder: 1062.9","Cell type enhanced","Detected in many",NA,"Endometrial stromal cells: 223.5;Extravillous trophoblasts: 531.3;Fibroblasts: 756.3;Leydig cells: 338.9;Peritubular cells: 406.2","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"testis cancer: 849.0","Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Prostate - Fibroblasts, Skin - Fibroblast_2, Stomach - Fibroblasts","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","HPA001939, CAB002788","Approved","","Approved","Vesicles","Secreted to extracellular matrix",NA,NA,1.6e+09,2.2e+08,"","Cluster 46: Fibroblasts - ECM organization","Cluster 59: Fibroblasts - Metabolism","Cluster 65: Fibroblasts - ECM organization","Vesicles","","CAB002788: , HPA001939: AB_1079395","unprognostic (7.26e-2)","unprognostic (1.36e-3)","unprognostic (1.66e-1)","unprognostic (2.14e-3)","unprognostic (5.03e-2)","unprognostic (1.20e-1)","unprognostic (1.74e-1)","unprognostic (9.36e-3)","unprognostic (4.81e-3)","unprognostic (3.79e-2)","unprognostic (4.59e-3)","unprognostic (6.12e-2)","unprognostic (1.28e-3)","unprognostic (1.59e-2)","unprognostic (8.00e-2)","unprognostic (8.98e-2)","unprognostic (4.63e-2)",7,0,9,16,"ENST00000543485; ENST00000564864",0,1,"Lung; Muscle","Idiopathic.Pulmonary.Fibrosis"
"MMP3","STMY, STMY1","ENSG00000149968","Matrix metallopeptidase 3","P08254","11","102835801-102843609","Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins","Collagen degradation","Hydrolase, Metalloprotease, Protease","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"adipose tissue: 90.7;salivary gland: 286.1","Cell type enhanced","Detected in some",NA,"Basal respiratory cells: 20.2;Early spermatids: 27.8;Extravillous trophoblasts: 16.7;Fibroblasts: 52.1;Pancreatic endocrine cells: 17.2;Smooth muscle cells: 17.7","Cancer enhanced","Detected in many",NA,"head and neck cancer: 59.9","Region enriched","Detected in some",4,"thalamus: 7.3","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Group enriched","Detected in many",10,"Brain cancer: 54.1;Sarcoma: 122.3","","Not detected","Not detected",NA,"","Region enhanced","Detected in some",NA,"hippocampal formation: 3.2","HPA007875","Uncertain","","Supported","Vesicles","Secreted to extracellular matrix",NA,NA,2540000,460000,"","Cluster 24: Salivary gland - Salivary secretion","Cluster 20: Connective tissue cells - ECM organization","Cluster 74: Pancreatic cells - Mixed function","Vesicles","","HPA007875: AB_1079396","unprognostic (2.27e-1)","prognostic unfavorable (9.73e-4)","unprognostic (1.63e-3)","unprognostic (5.11e-3)","unprognostic (3.78e-1)","unprognostic (5.11e-2)","unprognostic (5.26e-6)","unprognostic (3.46e-2)","unprognostic (7.14e-2)","unprognostic (2.87e-1)","prognostic unfavorable (4.09e-4)","unprognostic (3.26e-2)","unprognostic (1.22e-15)","unprognostic (3.17e-1)","unprognostic (1.55e-1)","unprognostic (3.43e-2)","unprognostic (2.34e-1)",6,6,3,15,NA,1,1,NA,"Idiopathic.Pulmonary.Fibrosis"
"MXRA5","DKFZp564I1922","ENSG00000101825","Matrix remodeling associated 5","Q9NR99","X","3308565-3346652","Cancer-related genes, Disease related genes, Predicted secreted proteins","","","Cancer-related genes","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 35.0","Cell type enhanced","Detected in many",NA,"Basal keratinocytes: 22.9;Basal prostatic cells: 30.2;Collecting duct cells: 27.6;Exocrine glandular cells: 69.1;Fibroblasts: 45.9;Salivary duct cells: 32.5","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in single",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"thyroid cancer: 41.3","Heart muscle - Fibroblasts, Liver - Hepatic stellate cells, Skin - Fibroblast_1","","",NA,"","Low region specificity","Detected in all",NA,"","HPA000508, HPA076518","Uncertain","","Uncertain","Mitochondria","Secreted to extracellular matrix",NA,NA,NA,2600000,"","Cluster 31: Skin - Epidermis development","Cluster 20: Connective tissue cells - ECM organization","Cluster 65: Fibroblasts - ECM organization","Mitochondria","","HPA000508: AB_2147995, HPA076518: ","unprognostic (7.51e-2)","unprognostic (6.45e-2)","unprognostic (8.00e-2)","unprognostic (2.51e-2)","prognostic unfavorable (1.81e-4)","unprognostic (7.05e-2)","unprognostic (7.25e-2)","unprognostic (1.35e-2)","unprognostic (1.13e-1)","unprognostic (2.53e-2)","unprognostic (6.32e-3)","unprognostic (1.38e-1)","unprognostic (1.65e-2)","unprognostic (1.58e-1)","unprognostic (1.90e-2)","unprognostic (1.50e-1)","prognostic unfavorable (8.94e-4)",8,0,8,16,NA,0,0,"Blood.Vessel",NA
"NID2","","ENSG00000087303","Nidogen 2","Q14112","14","52004803-52069228","Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion","","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"placenta: 60.8","Cell type enhanced","Detected in many",NA,"Adipocytes: 26.0;Fibroblasts: 43.4;Microglial cells: 19.2;Smooth muscle cells: 23.2;Theca cells: 33.9;Thymic epithelial cells: 24.3","Cancer enhanced","Detected in all",NA,"thyroid cancer: 15.7","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"ovarian cancer: 57.2","Liver - Hepatic stellate cells, Prostate - Fibroblasts","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","HPA052460, HPA058772","Enhanced","","Enhanced","Plasma membrane","Secreted to extracellular matrix",NA,NA,NA,6300000,"","Cluster 28: Placenta - Pregnancy","Cluster 59: Fibroblasts - Metabolism","Cluster 53: Connective tissue cells - ECM organization","Plasma membrane","","HPA052460: AB_2681840, HPA058772: AB_2683815","unprognostic (6.51e-2)","unprognostic (3.55e-3)","unprognostic (3.73e-2)","unprognostic (3.25e-2)","unprognostic (2.04e-1)","unprognostic (1.94e-1)","unprognostic (5.37e-2)","unprognostic (3.05e-3)","unprognostic (2.52e-3)","unprognostic (3.07e-2)","unprognostic (4.85e-2)","unprognostic (1.43e-1)","unprognostic (1.48e-3)","prognostic unfavorable (7.34e-4)","unprognostic (4.58e-2)","unprognostic (2.87e-2)","prognostic unfavorable (2.78e-4)",9,1,10,20,NA,0,0,NA,NA
"NPTX1","","ENSG00000171246","Neuronal pentraxin 1","Q15818","17","80466834-80477843","Predicted secreted proteins, Transporters","","","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Group enriched","Detected in many",5,"brain: 107.8;intestine: 31.6","Cell type enhanced","Detected in some",NA,"Cone photoreceptor cells: 239.5;Excitatory neurons: 87.2;Horizontal cells: 34.6;Late spermatids: 44.5","Cancer enhanced","Detected in many",NA,"glioma: 4.8","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Rhabdoid: 32.4","Testis - Late spermatids","Low region specificity","Detected in all",NA,"","Group enriched","Detected in all",4,"amygdala: 55.3;cerebellum: 128.1;cerebral cortex: 102.2;hippocampal formation: 131.3","HPA077062","Enhanced","Approved","","","Secreted in brain",NA,NA,NA,1100000,"","Cluster 6: Brain - Smell perception","Cluster 41: Non-specific - Cilium assembly","Cluster 38: Neurons - Neuronal signaling","","","HPA077062: AB_2732329","unprognostic (2.37e-2)","unprognostic (1.18e-1)","unprognostic (1.81e-2)","unprognostic (6.95e-2)","unprognostic (4.16e-3)","unprognostic (2.43e-2)","unprognostic (1.48e-2)","unprognostic (3.63e-1)","unprognostic (1.31e-2)","unprognostic (2.07e-1)","unprognostic (1.81e-2)","unprognostic (9.63e-3)","unprognostic (1.05e-6)","unprognostic (1.41e-4)","unprognostic (1.35e-1)","unprognostic (8.86e-6)","unprognostic (2.71e-3)",7,2,7,16,NA,0,0,"Lung",NA
"PAPPA","ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1","ENSG00000182752","Pappalysin 1","Q13219","9","116153791-116402321","Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins","","Hydrolase, Metalloprotease, Protease","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in many",8,"placenta: 72.3","Cell type enhanced","Detected in many",NA,"Basal squamous epithelial cells: 62.5;Collecting duct cells: 135.9;Endometrial stromal cells: 111.4;Horizontal cells: 59.0;Proximal tubular cells: 54.3;Thymic epithelial cells: 95.0","Low cancer specificity","Detected in some",NA,"","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Rhabdoid: 32.6","Colon - Enteric glia cells","Low region specificity","Detected in single",NA,"","Low region specificity","Detected in many",NA,"","HPA001667, CAB016724","Enhanced","","","","Secreted in female reproductive system",NA,NA,NA,7.8e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 22: Rhabdoid cancers - Neuronal signaling","Cluster 52: Endometrial stromal cells - ECM organization","","","CAB016724: , HPA001667: AB_1854960","unprognostic (3.25e-1)","unprognostic (6.18e-6)","unprognostic (2.47e-1)","unprognostic (6.49e-2)","unprognostic (2.01e-2)","unprognostic (1.14e-1)","unprognostic (1.13e-1)","unprognostic (5.42e-3)","unprognostic (5.44e-2)","unprognostic (3.87e-2)","unprognostic (6.87e-3)","unprognostic (8.25e-2)","unprognostic (8.00e-3)","unprognostic (2.37e-3)","unprognostic (2.48e-1)","unprognostic (4.01e-1)","unprognostic (1.02e-3)",9,8,10,27,NA,0,1,"Nerve","Idiopathic.Pulmonary.Fibrosis"
"PDCD1LG2","B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2","ENSG00000197646","Programmed cell death 1 ligand 2","Q9BQ51","9","5510531-5571282","Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins","Adaptive immunity, Immunity","Receptor","Cancer-related genes","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"lymphoid tissue: 15.1","Cell type enhanced","Detected in some",NA,"Extravillous trophoblasts: 21.9;Fibroblasts: 7.3;granulocytes: 12.6;Langerhans cells: 14.1;Leydig cells: 6.9;Microglial cells: 11.9","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in some",NA,"","Low immune cell specificity","Detected in some",NA,"","Low lineage specificity","Detected in many",NA,"","Low cancer specificity","Detected in many",NA,"","Breast - Fibroblasts, Kidney - Endothelial cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts","Not detected","Not detected",NA,"","Low region specificity","Detected in all",NA,"","HPA013411","Approved","","Uncertain","Cytosol","Secreted - unknown location",NA,NA,NA,3.1e+07,"Cluster 46: Basophils - DNA binding","Cluster 16: Immune cells - Immune response","Cluster 20: Connective tissue cells - ECM organization","Cluster 23: Langerhans cells - Immune response","Cytosol","","HPA013411: AB_1855102","unprognostic (3.93e-2)","unprognostic (1.90e-1)","unprognostic (3.51e-3)","unprognostic (6.68e-3)","unprognostic (7.66e-2)","unprognostic (6.77e-2)","unprognostic (5.72e-2)","unprognostic (2.91e-1)","unprognostic (1.68e-1)","unprognostic (4.37e-3)","unprognostic (5.79e-2)","unprognostic (5.29e-2)","prognostic unfavorable (1.15e-4)","unprognostic (5.00e-2)","unprognostic (4.66e-2)","unprognostic (2.01e-1)","unprognostic (7.51e-3)",12,11,9,32,"ENST00000397747",1,0,"Blood.Vessel",NA
"PLAT","","ENSG00000104368","Plasminogen activator, tissue type","P00750","8","42174718-42207709","Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins","Plasminogen activation","Hydrolase, Protease, Serine protease","Cancer-related genes, FDA approved drug targets","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"parathyroid gland: 246.0;urinary bladder: 181.4","Cell type enhanced","Detected in many",NA,"Adipocytes: 76.2;Basal respiratory cells: 135.4;Breast glandular cells: 100.4;Endometrial stromal cells: 103.1;Endothelial cells: 98.4;Fibroblasts: 92.8;Granulosa cells: 85.4","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"skin cancer: 260.2","Kidney - Endothelial cells, Prostate - Urothelial cells, Testis - Sertoli cells, Thyroid - Fibroblasts","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA003412, CAB009335","Supported","","Approved","Actin filaments","Secreted to blood",NA,NA,9900000,110000,"Cluster 4: T-regs - Cell cycle regulation","Cluster 48: Parathyroid gland - membrane proteins","Cluster 20: Connective tissue cells - ECM organization","Cluster 66: Endothelial cells - Angiogenesis","Actin filaments","","CAB009335: AB_2237146, HPA003412: AB_1858205","prognostic favorable (7.57e-4)","unprognostic (2.23e-1)","unprognostic (4.08e-1)","unprognostic (3.39e-1)","unprognostic (4.88e-3)","unprognostic (9.39e-2)","unprognostic (4.65e-3)","unprognostic (5.78e-2)","unprognostic (1.55e-1)","unprognostic (1.75e-1)","unprognostic (2.98e-3)","unprognostic (2.46e-1)","prognostic unfavorable (4.95e-4)","unprognostic (8.72e-3)","unprognostic (1.37e-2)","unprognostic (2.63e-2)","unprognostic (6.09e-2)",9,0,9,18,"ENST00000352041; ENST00000519510",1,1,"Blood.Vessel; Muscle",NA
"PLAU","UPA, URK","ENSG00000122861","Plasminogen activator, urokinase","P00749","10","73909177-73917496","Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins","Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation","Hydrolase, Protease, Serine protease","Cancer-related genes","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"kidney: 103.8;urinary bladder: 128.5","Cell type enhanced","Detected in many",NA,"Basal respiratory cells: 215.4;Collecting duct cells: 90.6;Exocrine glandular cells: 124.9;Ionocytes: 131.6","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Group enriched","Detected in some",9,"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0","Group enriched","Detected in many",11,"dendritic cells: 2.0;granulocytes: 2.1","Low cancer specificity","Detected in all",NA,"","","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","HPA070796","Supported","","Uncertain","Golgi apparatus,Vesicles","Secreted to blood",NA,NA,647000,88000,"Cluster 8: Neutrophils - Inflammatory response","Cluster 82: Adipose tissue - ECM organization","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 74: Pancreatic cells - Mixed function","Golgi apparatus, Vesicles","","HPA070796: ","unprognostic (1.96e-2)","unprognostic (2.99e-2)","unprognostic (7.40e-2)","prognostic favorable (3.38e-4)","unprognostic (4.73e-2)","prognostic unfavorable (2.70e-4)","unprognostic (1.39e-2)","prognostic unfavorable (4.04e-4)","unprognostic (2.26e-1)","unprognostic (6.58e-2)","prognostic unfavorable (1.32e-4)","unprognostic (1.61e-1)","prognostic unfavorable (3.51e-4)","unprognostic (2.83e-1)","unprognostic (3.37e-2)","unprognostic (1.51e-2)","unprognostic (1.77e-2)",7,3,8,18,NA,0,1,NA,NA
"PSG1","CD66f, PBG1, PSBG1, PSGGA","ENSG00000231924","Pregnancy specific beta-1-glycoprotein 1","P11464","19","42866464-42879822","CD markers, Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in some",161,"placenta: 259.7","Cell type enriched","Detected in some",92,"Syncytiotrophoblasts: 202.8","Cancer enhanced","Detected in single",NA,"thyroid cancer: 0.5","Low region specificity","Detected in single",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"thyroid cancer: 166.9","","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,7.5e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 20: Connective tissue cells - ECM organization","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","","","","","unprognostic (2.02e-1)","unprognostic (3.54e-1)","","","","","","","unprognostic (2.44e-7)","","","unprognostic (2.28e-2)","",8,10,2,20,NA,1,0,NA,NA
"PSG2","CEA, PSBG2, PSG1, PSGGB","ENSG00000242221","Pregnancy specific beta-1-glycoprotein 2","P11465","19","43064209-43083045","Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at transcript level","Evidence at transcript level","Evidence at protein level","Tissue enriched","Detected in some",204,"placenta: 238.5","Cell type enriched","Detected in some",23,"Syncytiotrophoblasts: 763.2","Not detected","Not detected",NA,"","Low region specificity","Detected in single",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"breast cancer: 8.0;Sarcoma: 9.7;testis cancer: 9.4","","","",NA,"","","",NA,"","","","","","","Secreted in female reproductive system",NA,NA,NA,4.1e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 20: Connective tissue cells - ECM organization","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","","","","","","","","","","","","","","","unprognostic (1.02e-2)","","","",0,12,0,12,NA,1,0,NA,NA
"PSG3","","ENSG00000221826","Pregnancy specific beta-1-glycoprotein 3","Q16557","19","42721638-42740481","Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Tissue enriched","Detected in single",199,"placenta: 141.5","Cell type enriched","Detected in some",81,"Syncytiotrophoblasts: 1431.2","Not detected","Not detected",NA,"","Not detected","Not detected",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in some",NA,"Kidney cancer: 2.3;Rhabdoid: 2.8;thyroid cancer: 3.0","","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,6.7e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 68: Kidney - Mixed function","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","","","","","","","","","","","","","","","","","",1,10,0,11,NA,0,0,NA,NA
"PSG4","","ENSG00000243137","Pregnancy specific beta-1-glycoprotein 4","Q00888","19","43192702-43207299","Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Group enriched","Detected in some",30,"parathyroid gland: 55.6;placenta: 143.4","Cell type enriched","Detected in some",41,"Syncytiotrophoblasts: 561.0","Low cancer specificity","Detected in some",NA,"","Not detected","Not detected",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,5.8e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 20: Connective tissue cells - ECM organization","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","unprognostic (4.29e-2)","unprognostic (5.18e-2)","","unprognostic (9.49e-2)","","unprognostic (2.52e-2)","","unprognostic (3.63e-2)","unprognostic (1.94e-1)","unprognostic (2.07e-2)","unprognostic (1.70e-1)","unprognostic (7.75e-2)","unprognostic (8.82e-3)","unprognostic (1.03e-3)","unprognostic (1.68e-2)","unprognostic (2.85e-1)","unprognostic (2.57e-1)",6,11,6,23,"ENST00000244295; ENST00000451895; ENST00000597912; ENST00000601041",1,0,NA,NA
"PSG5","FL-NCA-3, PSG","ENSG00000204941","Pregnancy specific beta-1-glycoprotein 5","Q15238","19","43166256-43186536","Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in some",63,"placenta: 111.8","Cell type enriched","Detected in some",39,"Syncytiotrophoblasts: 702.8","Cancer enhanced","Detected in single",NA,"urothelial cancer: 0.5","Region enhanced","Detected in single",NA,"cerebellum: 1.7","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","Pancreas - Ductal cells","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,2.2e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 20: Connective tissue cells - ECM organization","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","unprognostic (1.59e-1)","unprognostic (3.38e-2)","","","","unprognostic (4.69e-2)","","unprognostic (1.62e-2)","unprognostic (2.18e-1)","unprognostic (2.04e-1)","unprognostic (1.75e-2)","","unprognostic (1.12e-2)","unprognostic (2.62e-2)","","unprognostic (1.03e-1)","unprognostic (7.92e-2)",9,12,9,30,"ENST00000342951; ENST00000366175",1,0,NA,NA
"PSG6","","ENSG00000170848","Pregnancy specific beta-1-glycoprotein 6","Q00889","19","42902086-42919563","Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Tissue enriched","Detected in some",35,"placenta: 49.4","Cell type enriched","Detected in some",120,"Syncytiotrophoblasts: 381.4","Not detected","Not detected",NA,"","Region enhanced","Detected in single",NA,"cerebellum: 1.4","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Group enriched","Detected in some",8,"Sarcoma: 10.7;testis cancer: 3.9","","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,6.5e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 20: Connective tissue cells - ECM organization","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","","","","","","unprognostic (4.23e-1)","","","","","","","","","","","",4,12,1,17,NA,1,0,NA,NA
"PSG7","","ENSG00000221878","Pregnancy specific beta-1-glycoprotein 7","Q13046","19","42924132-42937207","Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","","","Group enriched","Detected in some",4,"placenta: 4.1;skin 1: 1.2","Cell type enriched","Detected in some",75,"Syncytiotrophoblasts: 129.6","Not detected","Not detected",NA,"","Not detected","Not detected",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enriched","Detected in some",4,"Rhabdoid: 6.3","Skin - Keratinocyte (granular)","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,NA,"","Cluster 28: Placenta - Pregnancy","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","","","","","","","","","","","","","","","","","",1,12,0,13,NA,1,0,NA,NA
"PSG8","","ENSG00000124467","Pregnancy specific beta-1-glycoprotein 8","Q9UQ74","19","42752686-42855691","Predicted intracellular proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Tissue enriched","Detected in single",24,"placenta: 6.5","Cell type enriched","Detected in some",11,"Syncytiotrophoblasts: 39.2","Cancer enriched","Detected in single",17,"thyroid cancer: 0.8","Not detected","Not detected",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in some",NA,"Gastric cancer: 2.8","","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,5.5e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 60: Keratinocytes - Epithelial cell function","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","","","","","","","","","","","","","","","","unprognostic (1.85e-2)","",3,9,1,13,NA,0,0,NA,NA
"PSG9","PSG11, PSGII","ENSG00000183668","Pregnancy specific beta-1-glycoprotein 9","Q00887","19","43211791-43269530","Plasma proteins, Predicted membrane proteins, Predicted secreted proteins","","","","Evidence at protein level","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Tissue enriched","Detected in single",135,"placenta: 106.3","Cell type enriched","Detected in some",25,"Syncytiotrophoblasts: 222.5","Not detected","Not detected",NA,"","Not detected","Not detected",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"breast cancer: 27.5;Rhabdoid: 25.3","","","",NA,"","","",NA,"","HPA046327","Supported","","","","Secreted in female reproductive system",NA,NA,NA,4.3e+07,"","Cluster 28: Placenta - Pregnancy","Cluster 20: Connective tissue cells - ECM organization","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","HPA046327: AB_2679624","unprognostic (9.32e-2)","unprognostic (3.28e-1)","","","","unprognostic (2.15e-1)","","","","","","","","","","","",0,11,0,11,"ENST00000621109",1,0,NA,NA
"RELN","PRO1598, RL","ENSG00000189056","Reelin","P78509","7","103471381-103989658","Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins","Cell adhesion","Developmental protein, Hydrolase, Protease, Serine protease","Disease variant, Epilepsy, Lissencephaly","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in some",5,"brain: 64.4","Cell type enriched","Detected in many",4,"Inhibitory neurons: 364.2","Cancer enhanced","Detected in many",NA,"liver cancer: 5.7","Region enriched","Detected in many",10,"cerebellum: 64.4","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Kidney cancer: 17.6;liver cancer: 11.0;Myeloma: 10.7","Pancreas - Fibroblasts, Testis - Late spermatids","Low region specificity","Detected in all",NA,"","Region enhanced","Detected in all",NA,"cerebellum: 110.0","HPA077891","","","Approved","Golgi apparatus,Vesicles","Secreted in brain",NA,NA,NA,3e+07,"","Cluster 69: Cerebellum - Gene expression regulation","Cluster 68: Kidney - Mixed function","Cluster 37: Neurons - Neuronal signaling","Golgi apparatus","Vesicles","HPA077891: ","unprognostic (1.42e-1)","unprognostic (2.93e-3)","unprognostic (4.31e-2)","unprognostic (1.29e-4)","unprognostic (1.30e-1)","unprognostic (6.95e-2)","unprognostic (1.85e-1)","unprognostic (8.35e-2)","unprognostic (1.54e-1)","unprognostic (1.48e-2)","unprognostic (3.31e-3)","unprognostic (3.86e-1)","unprognostic (2.02e-2)","unprognostic (1.43e-2)","unprognostic (3.03e-1)","unprognostic (1.35e-1)","unprognostic (3.06e-2)",7,0,5,12,NA,0,0,"Muscle",NA
"RSPO1","FLJ40906, RSPONDIN","ENSG00000169218","R-spondin 1","Q2MKA7","1","37611350-37634892","Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins","Sensory transduction, Wnt signaling pathway","Heparin-binding","Palmoplantar keratoderma","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 28.9;endometrium 1: 41.4","Group enriched","Detected in some",4,"Breast glandular cells: 12.2;Breast myoepithelial cells: 18.1;Thymic epithelial cells: 33.7","Cancer enriched","Detected in some",13,"ovarian cancer: 11.8","Not detected","Not detected",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Not detected","Not detected",NA,"","Adipose visceral - Mesothelial cells","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in some",NA,"","HPA046154, HPA062923","Uncertain","","Approved","Vesicles","Secreted in female reproductive system",NA,NA,NA,NA,"","Cluster 89: Fibroblasts - ECM organization","Cluster 47: Retina - Visual perception","Cluster 73: Prostatic glandular cells - Transcription","Vesicles","","HPA046154: AB_10964912, HPA062923: ","unprognostic (1.50e-2)","unprognostic (1.97e-3)","unprognostic (5.99e-3)","unprognostic (2.22e-1)","unprognostic (1.76e-1)","unprognostic (3.75e-6)","","unprognostic (1.84e-2)","unprognostic (1.48e-1)","unprognostic (1.27e-1)","unprognostic (2.08e-1)","unprognostic (1.13e-2)","","unprognostic (1.93e-2)","unprognostic (3.76e-2)","unprognostic (3.21e-1)","unprognostic (1.53e-2)",7,6,7,20,NA,0,0,NA,NA
"SEMA3A","coll-1, Hsema-I, SEMA1, SEMAD, SemD","ENSG00000075213","Semaphorin 3A","Q14563","7","83955777-84492724","Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Differentiation, Neurogenesis","Developmental protein","Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"retina: 22.6","Cell type enhanced","Detected in many",NA,"Astrocytes: 56.6;Cone photoreceptor cells: 24.1;Excitatory neurons: 88.4;Horizontal cells: 25.6;Rod photoreceptor cells: 66.2","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","Immune cell enriched","Detected in single",5,"non-classical monocyte: 1.5","Lineage enriched","Detected in single",16,"monocytes: 1.5","Low cancer specificity","Detected in all",NA,"","","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","HPA029447, HPA052235","Approved","","Approved","Vesicles","Secreted in other tissues",NA,NA,NA,1600000,"Cluster 7: Monocytes - Unknown function","Cluster 77: Retina - Visual perception","Cluster 34: Rabdoid cancer - Embryonic development","Cluster 66: Endothelial cells - Angiogenesis","Vesicles","","HPA029447: AB_10602302, HPA052235: AB_2681770","unprognostic (1.20e-1)","prognostic unfavorable (2.69e-5)","unprognostic (1.51e-1)","unprognostic (5.82e-2)","unprognostic (1.37e-2)","unprognostic (5.98e-3)","unprognostic (2.92e-3)","unprognostic (6.05e-3)","unprognostic (1.13e-1)","unprognostic (2.48e-1)","unprognostic (1.46e-1)","unprognostic (4.44e-2)","unprognostic (6.18e-12)","unprognostic (3.26e-2)","unprognostic (2.41e-2)","unprognostic (1.61e-2)","unprognostic (1.47e-4)",3,2,9,14,"ENST00000436949",0,0,"Blood.Vessel",NA
"SERPINE1","PAI, PAI1, PLANH1","ENSG00000106366","Serpin family E member 1","P05121","7","101127104-101139247","Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins","","Protease inhibitor, Serine protease inhibitor","Cancer-related genes, FDA approved drug targets","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"placenta: 418.0","Group enriched","Detected in many",4,"Fibroblasts: 205.9;Pancreatic endocrine cells: 472.3;Syncytiotrophoblasts: 748.4","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Immune cell enriched","Detected in single",20,"NK-cell: 9.5","Lineage enriched","Detected in single",20,"NK-cells: 9.5","Cancer enhanced","Detected in all",NA,"Kidney cancer: 1244.1","Colon - Neutrophils","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","CAB068501","Uncertain","","","","Secreted to blood",NA,"No",1.42e+08,1.3e+07,"Cluster 22: NK-cells - Unknown function","Cluster 86: Liver & Placenta - Transport via ER","Cluster 20: Connective tissue cells - ECM organization","Cluster 74: Pancreatic cells - Mixed function","","","CAB068501: AB_1642775","unprognostic (5.02e-2)","prognostic unfavorable (5.01e-4)","prognostic unfavorable (2.82e-4)","unprognostic (2.10e-2)","unprognostic (9.04e-3)","prognostic unfavorable (2.84e-5)","unprognostic (6.80e-3)","prognostic unfavorable (4.41e-6)","unprognostic (2.33e-1)","unprognostic (1.45e-1)","unprognostic (2.88e-3)","unprognostic (1.58e-1)","prognostic unfavorable (5.88e-8)","prognostic unfavorable (3.27e-6)","unprognostic (1.05e-1)","unprognostic (4.33e-2)","prognostic unfavorable (5.51e-4)",8,0,12,20,NA,0,1,"Blood.Vessel; Brain",NA
"SERPINE2","GDN, nexin, PI7, PN1, PNI","ENSG00000135919","Serpin family E member 2","P07093","2","223975045-224039318","Plasma proteins, Predicted secreted proteins","Differentiation, Neurogenesis","Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in all",7,"placenta: 1091.9","Cell type enriched","Detected in many",7,"Granulosa cells: 4370.2","Cancer enriched","Detected in all",9,"melanoma: 271.6","Low region specificity","Detected in all",NA,"","Group enriched","Detected in some",12,"naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2","Group enriched","Detected in many",15,"NK-cells: 23.2;T-cells: 12.9","Cancer enriched","Detected in all",5,"skin cancer: 2476.4","Liver - Hepatic stellate cells","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA000277","","","Approved","Golgi apparatus","Secreted in female reproductive system",NA,NA,NA,910000,"Cluster 48: NK-cells - Unknown function","Cluster 28: Placenta - Pregnancy","Cluster 33: Skin cancer - Membrane components","Cluster 17: Granulosa cells - Transcription regulation","Golgi apparatus","","HPA000277: ","unprognostic (1.73e-1)","unprognostic (7.08e-3)","unprognostic (8.49e-2)","unprognostic (7.78e-3)","unprognostic (2.57e-3)","unprognostic (5.57e-2)","unprognostic (1.49e-2)","unprognostic (7.43e-3)","unprognostic (4.41e-1)","unprognostic (7.12e-2)","unprognostic (7.56e-3)","unprognostic (2.40e-1)","unprognostic (1.97e-3)","unprognostic (1.23e-2)","unprognostic (1.31e-1)","unprognostic (6.18e-2)","prognostic unfavorable (6.48e-5)",2,0,9,11,"ENST00000478966",0,1,NA,"Idiopathic.Pulmonary.Fibrosis; Heart.Failure"
"SFRP1","FRP, FRP-1, SARP2","ENSG00000104332","Secreted frizzled related protein 1","Q8N474","8","41261962-41309473","Predicted intracellular proteins, Predicted secreted proteins","Differentiation, Wnt signaling pathway","Developmental protein","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"breast: 299.3;choroid plexus: 509.2","Cell type enhanced","Detected in many",NA,"Breast glandular cells: 756.9;Breast myoepithelial cells: 1192.4;Cardiomyocytes: 308.6;Leydig cells: 606.9;Serous glandular cells: 437.9","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Group enriched","Detected in many",5,"breast cancer: 115.5;Neuroblastoma: 67.0;skin cancer: 78.8;testis cancer: 264.7;thyroid cancer: 81.2","Heart muscle - Cardiomyocytes, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Pancreas - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Eccrine sweat gland cells","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","CAB008116","Approved","","","","Secreted in other tissues",NA,"No",NA,1300000,"","Cluster 42: Ciliated cells - Cilium & Cell projection","Cluster 20: Connective tissue cells - ECM organization","Cluster 21: Serous glandular cells - Salivary secretion","","","CAB008116: AB_2187070","unprognostic (1.23e-3)","unprognostic (7.01e-2)","unprognostic (2.14e-1)","unprognostic (3.59e-1)","unprognostic (7.13e-2)","prognostic favorable (1.55e-4)","unprognostic (1.79e-1)","unprognostic (2.69e-3)","unprognostic (2.15e-2)","unprognostic (4.67e-3)","unprognostic (3.52e-3)","unprognostic (4.74e-2)","unprognostic (1.72e-2)","unprognostic (1.75e-2)","unprognostic (1.28e-1)","unprognostic (2.57e-1)","prognostic unfavorable (3.12e-4)",9,0,9,18,NA,0,0,"Muscle",NA
"SPARC","BM-40, ON, ONT","ENSG00000113140","Secreted protein acidic and cysteine rich","P09486","5","151661096-151686975","Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","","","Cancer-related genes, Disease variant, Osteogenesis imperfecta","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"placenta: 2184.6","Cell type enhanced","Detected in many",NA,"Adipocytes: 690.5;Endometrial stromal cells: 1211.8;Endothelial cells: 711.5;Fibroblasts: 1071.9;Peritubular cells: 1109.1;Schwann cells: 921.2;Sertoli cells: 1409.7;Smooth muscle cells: 1089.7;Theca cells: 924.5","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Group enriched","Detected in many",5,"basophil: 10.4;classical monocyte: 8.7;neutrophil: 24.3","Group enriched","Detected in many",7,"granulocytes: 24.3;monocytes: 8.7","Cancer enhanced","Detected in all",NA,"Brain cancer: 2554.7;skin cancer: 2512.0","Colon - Enteric glia cells, Prostate - Fibroblasts, Skin - Fibroblast_1","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","CAB002306, HPA002989, HPA003020","Supported","","Approved","Vesicles","Secreted to blood",NA,NA,8300000,1.3e+08,"Cluster 34: Basophils - Unknown function","Cluster 57: Non-specific - Angiogenesis","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Vesicles","","CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531","unprognostic (3.34e-2)","unprognostic (8.57e-2)","unprognostic (1.31e-1)","unprognostic (3.97e-1)","unprognostic (7.01e-2)","unprognostic (1.49e-1)","unprognostic (2.05e-1)","unprognostic (8.36e-3)","unprognostic (5.27e-2)","unprognostic (1.22e-1)","unprognostic (4.09e-2)","unprognostic (1.78e-1)","prognostic unfavorable (3.53e-5)","unprognostic (2.59e-3)","unprognostic (1.17e-2)","unprognostic (3.53e-1)","unprognostic (4.93e-3)",0,0,12,12,"ENST00000539687",1,0,NA,NA
"STC1","STC","ENSG00000159167","Stanniocalcin 1","P52823","8","23841929-23854806","Predicted intracellular proteins, Predicted secreted proteins","","Hormone","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"thyroid gland: 64.3","Cell type enhanced","Detected in many",NA,"Adipocytes: 166.0;Collecting duct cells: 72.9;Endometrial ciliated cells: 84.2;Endothelial cells: 178.7;Glandular and luminal cells: 306.8;Theca cells: 151.6","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"Sarcoma: 56.9","","Low region specificity","Detected in many",NA,"","Low region specificity","Detected in many",NA,"","CAB018625, HPA023918","Approved","","","","Secreted in other tissues",NA,NA,NA,240000,"","Cluster 82: Adipose tissue - ECM organization","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 14: Endometrium - Transcription regulation","","","CAB018625: AB_2197536, HPA023918: AB_1857566","unprognostic (1.18e-1)","prognostic unfavorable (8.45e-4)","unprognostic (3.58e-2)","unprognostic (2.13e-1)","prognostic unfavorable (6.44e-5)","prognostic unfavorable (6.32e-4)","unprognostic (2.84e-2)","prognostic unfavorable (1.53e-4)","unprognostic (4.82e-2)","unprognostic (1.44e-2)","unprognostic (7.61e-2)","unprognostic (1.60e-1)","prognostic unfavorable (1.23e-6)","prognostic unfavorable (5.55e-4)","unprognostic (2.79e-1)","unprognostic (1.19e-3)","unprognostic (8.95e-3)",10,0,7,17,NA,1,0,"Blood.Vessel; Heart; Muscle",NA
"STC2","STC-2","ENSG00000113739","Stanniocalcin 2","O76061","5","173314723-173328447","Predicted intracellular proteins, Predicted secreted proteins","","Hormone","","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in many",4,"breast: 143.6","Cell type enhanced","Detected in many",NA,"Breast glandular cells: 239.4;Breast myoepithelial cells: 120.9;Exocrine glandular cells: 41.5;Extravillous trophoblasts: 63.8;Pancreatic endocrine cells: 53.2","Cancer enriched","Detected in all",6,"breast cancer: 91.4","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in all",NA,"","Skin - Macrophages","Low region specificity","Detected in single",NA,"","Low region specificity","Detected in some",NA,"","HPA045372","Approved","","Approved","Endoplasmic reticulum","Secreted in other tissues",NA,NA,NA,1.9e+07,"","Cluster 5: Breast - Unknown function","Cluster 20: Connective tissue cells - ECM organization","Cluster 73: Prostatic glandular cells - Transcription","Endoplasmic reticulum","","HPA045372: AB_10961040","prognostic favorable (7.40e-5)","unprognostic (2.40e-2)","unprognostic (9.03e-3)","unprognostic (1.21e-1)","unprognostic (1.89e-3)","prognostic unfavorable (1.76e-6)","prognostic unfavorable (3.07e-5)","unprognostic (5.28e-3)","unprognostic (6.12e-3)","unprognostic (1.53e-1)","unprognostic (2.13e-1)","unprognostic (3.19e-1)","prognostic unfavorable (4.17e-8)","prognostic unfavorable (7.57e-4)","unprognostic (8.56e-2)","unprognostic (5.06e-2)","unprognostic (7.93e-3)",9,8,12,29,"ENST00000519511",1,0,NA,NA
"TEK","CD202b, TIE-2, TIE2, VMCM, VMCM1","ENSG00000120156","TEK receptor tyrosine kinase","Q02763","9","27109141-27230174","Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins","Angiogenesis","Kinase, Receptor, Transferase, Tyrosine-protein kinase","Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"placenta: 46.3","Group enriched","Detected in some",6,"Adipocytes: 67.9;Endothelial cells: 76.7;Microglial cells: 37.4;Oligodendrocyte precursor cells: 131.9","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Group enriched","Detected in many",6,"Rhabdoid: 16.9;testis cancer: 18.3","Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Lung - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid - Endothelial cells","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","CAB010359, HPA073265","Approved","","Supported","Plasma membrane,Centriolar satellite","Secreted to blood",NA,NA,7750000,1.3e+07,"Cluster 9: Neutrophils - Innate immune response","Cluster 82: Adipose tissue - ECM organization","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 66: Endothelial cells - Angiogenesis","Plasma membrane","Centriolar satellite","CAB010359: AB_2203226, HPA073265: AB_2686592","unprognostic (2.24e-1)","unprognostic (1.74e-1)","unprognostic (5.55e-2)","unprognostic (1.83e-2)","unprognostic (1.68e-1)","unprognostic (1.26e-3)","prognostic favorable (2.31e-5)","unprognostic (7.48e-2)","unprognostic (1.72e-2)","unprognostic (1.41e-1)","unprognostic (5.58e-2)","unprognostic (2.72e-1)","prognostic favorable (7.81e-4)","unprognostic (7.50e-3)","unprognostic (6.87e-3)","unprognostic (1.83e-1)","unprognostic (5.24e-3)",9,0,6,15,"ENST00000406359",0,0,NA,NA
"TFPI2","PP5, REF1, TFPI-2","ENSG00000105825","Tissue factor pathway inhibitor 2","P48307","7","93885396-93890753","Predicted intracellular proteins, Predicted secreted proteins","Blood coagulation, Hemostasis","Protease inhibitor, Serine protease inhibitor","","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enriched","Detected in many",12,"placenta: 954.6","Cell type enhanced","Detected in many",NA,"Ductal cells: 1245.7;Glandular and luminal cells: 554.1;Pancreatic endocrine cells: 441.4;Syncytiotrophoblasts: 2047.0","Cancer enhanced","Detected in all",NA,"renal cancer: 65.9","Low region specificity","Detected in many",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in all",NA,"thyroid cancer: 892.8","Adipose subcutaneous - Endothelial cells, Adipose visceral - Mesothelial cells, Liver - Vascular Endothelial cells, Pancreas - Ductal cells","Not detected","Not detected",NA,"","Region enhanced","Detected in all",NA,"spinal cord: 29.7","CAB010142, HPA049158, HPA070525","Enhanced","","","","Secreted to extracellular matrix",NA,NA,NA,51000,"","Cluster 28: Placenta - Pregnancy","Cluster 37: Ovarian cancer RMG-I - Cellular stress response","Cluster 67: Syncytiotrophoblasts - Pregnancy","","","CAB010142: AB_628166, HPA049158: AB_2680659, HPA070525: ","prognostic favorable (8.33e-7)","unprognostic (2.20e-2)","unprognostic (2.10e-2)","prognostic favorable (5.42e-4)","unprognostic (5.19e-3)","unprognostic (3.98e-2)","unprognostic (1.38e-1)","unprognostic (2.72e-2)","unprognostic (1.15e-2)","unprognostic (6.86e-2)","unprognostic (7.54e-3)","unprognostic (7.01e-2)","prognostic unfavorable (8.53e-4)","unprognostic (3.38e-3)","unprognostic (3.65e-2)","unprognostic (1.97e-1)","unprognostic (7.91e-2)",5,4,2,11,NA,0,0,NA,NA
"TGFBI","BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1","ENSG00000120708","Transforming growth factor beta induced","Q15582","5","136028988-136063818","Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion, Sensory transduction, Vision","","Amyloidosis, Corneal dystrophy, Disease variant","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in all",NA,"placenta: 457.6","Cell type enhanced","Detected in many",NA,"dendritic cells: 342.9;Exocrine glandular cells: 348.9;Fibroblasts: 230.1;Hofbauer cells: 281.9;Kupffer cells: 193.4;Langerhans cells: 261.6;Macrophages: 234.6;Pancreatic endocrine cells: 736.8","Low cancer specificity","Detected in all",NA,"","Region enhanced","Detected in all",NA,"thalamus: 77.3","Group enriched","Detected in many",32,"classical monocyte: 252.3;intermediate monocyte: 149.1;myeloid DC: 156.9;non-classical monocyte: 121.4;plasmacytoid DC: 324.5","Group enriched","Detected in all",46,"dendritic cells: 324.5;monocytes: 252.3","Cancer enhanced","Detected in all",NA,"Kidney cancer: 2229.1","Heart muscle - Fibroblasts","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","HPA008612, HPA017019","Enhanced","","","","Secreted to blood",NA,NA,NA,1.6e+09,"Cluster 25: Monocytes - Inflammatory response","Cluster 28: Placenta - Pregnancy","Cluster 68: Kidney - Mixed function","Cluster 53: Connective tissue cells - ECM organization","","","HPA008612: AB_1857970, HPA017019: AB_2669511","unprognostic (1.05e-1)","prognostic unfavorable (1.03e-5)","unprognostic (4.38e-3)","prognostic favorable (1.17e-4)","unprognostic (5.21e-3)","unprognostic (5.53e-3)","unprognostic (4.60e-2)","unprognostic (8.71e-3)","unprognostic (5.45e-2)","prognostic unfavorable (1.14e-5)","unprognostic (1.42e-3)","unprognostic (2.26e-1)","prognostic unfavorable (7.82e-10)","unprognostic (8.81e-3)","unprognostic (1.73e-2)","unprognostic (3.42e-1)","unprognostic (1.70e-3)",4,0,10,14,"ENST00000507018",0,0,NA,NA
"THSD4","ADAMTSL6, FLJ13710, FVSY9334, PRO34005","ENSG00000187720","Thrombospondin type 1 domain containing 4","Q6ZMP0","15","71096952-71783383","Predicted membrane proteins, Predicted secreted proteins","","Hydrolase","","Evidence at protein level","Evidence at transcript level","Evidence at transcript level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"cervix: 103.7","Cell type enhanced","Detected in many",NA,"Basal squamous epithelial cells: 325.4;Microglial cells: 240.8;Squamous epithelial cells: 111.1","Cancer enhanced","Detected in many",NA,"ovarian cancer: 18.1","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Low cancer specificity","Detected in many",NA,"","Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Mesothelial cells, Heart muscle - Cardiomyocytes, Kidney - Fibroblasts, Testis - Peritubular cells, Thyroid - Thyroid glandular cells","Low region specificity","Detected in all",NA,"","Region enriched","Detected in many",4,"spinal cord: 39.0","","","","","","Secreted - unknown location",NA,NA,NA,NA,"","Cluster 11: Squamous epithelial cells - Epithelial cell function","Cluster 3: HUVEC & TIME - Signal transduction","Cluster 22: Squamous epithelial cells - Keratinization","","","","unprognostic (1.59e-1)","unprognostic (4.38e-2)","unprognostic (3.14e-2)","unprognostic (1.04e-1)","unprognostic (1.52e-1)","unprognostic (2.82e-2)","unprognostic (2.63e-2)","unprognostic (1.14e-1)","unprognostic (7.80e-2)","unprognostic (2.51e-2)","unprognostic (1.13e-1)","unprognostic (9.67e-2)","unprognostic (1.43e-1)","unprognostic (3.64e-1)","unprognostic (1.30e-1)","unprognostic (1.33e-2)","unprognostic (3.01e-3)",1,0,10,11,NA,0,0,NA,NA
"TNFRSF11B","OCIF, OPG, TR1","ENSG00000164761","TNF receptor superfamily member 11b","O00300","8","118923557-118951885","Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins","Apoptosis","Receptor","Cancer-related genes, Disease variant","Evidence at protein level","Evidence at protein level","Evidence at protein level","Evidence at protein level","Group enriched","Detected in many",5,"kidney: 29.9;thyroid gland: 101.8","Cell type enhanced","Detected in many",NA,"Breast glandular cells: 130.5;Collecting duct cells: 65.0;Pancreatic endocrine cells: 32.6;Proximal tubular cells: 107.7;Thymic epithelial cells: 81.8","Cancer enhanced","Detected in all",NA,"renal cancer: 22.7","Low region specificity","Detected in all",NA,"","Immune cell enriched","Detected in single",40,"plasmacytoid DC: 3.9","Lineage enriched","Detected in single",40,"dendritic cells: 3.9","Low cancer specificity","Detected in many",NA,"","Thyroid - Thyroid glandular cells","Low region specificity","Detected in all",NA,"","","",NA,"","CAB034939, HPA058613","Approved","","Approved","Nucleoplasm,Nucleoli,Golgi apparatus","Secreted in other tissues",NA,NA,NA,NA,"Cluster 47: Plasmacytoid DCs - Protein folding","Cluster 7: Kidney - Transmembrane transport","Cluster 20: Connective tissue cells - ECM organization","Cluster 30: Breast - Lactation","Golgi apparatus","Nucleoplasm, Nucleoli","CAB034939: , HPA058613: ","unprognostic (1.39e-2)","prognostic unfavorable (6.22e-4)","unprognostic (5.27e-2)","unprognostic (2.33e-2)","unprognostic (4.27e-3)","unprognostic (1.10e-3)","unprognostic (1.21e-3)","unprognostic (5.50e-2)","unprognostic (9.94e-2)","unprognostic (6.32e-2)","unprognostic (3.53e-2)","unprognostic (2.43e-1)","prognostic favorable (6.79e-4)","unprognostic (1.32e-2)","unprognostic (4.52e-2)","unprognostic (1.61e-3)","prognostic unfavorable (3.88e-4)",12,12,12,36,"ENST00000297350; ENST00000517352; ENST00000521597",0,1,"Blood.Vessel; Brain",NA
"WFDC1","PS20","ENSG00000103175","WAP four-disulfide core domain 1","Q9HC57","16","84294846-84329844","Predicted secreted proteins","","Protease inhibitor, Serine protease inhibitor","","Evidence at protein level","Evidence at transcript level","Evidence at transcript level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"placenta: 99.8;seminal vesicle: 115.1","Group enriched","Detected in many",4,"Bipolar cells: 92.8;Peritubular cells: 261.3;Smooth muscle cells: 103.1;Theca cells: 302.6","Low cancer specificity","Detected in many",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in some",NA,"cervical cancer: 19.1;skin cancer: 64.0","Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Colon - Smooth muscle cells, Heart muscle - Smooth muscle cells, Liver - Hepatic stellate cells, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Stomach - Fibroblasts, Testis - Peritubular cells","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","HPA031411","Uncertain","","","","Secreted to extracellular matrix",NA,NA,NA,NA,"","Cluster 12: Smooth muscle tissue - Mixed function","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","","","HPA031411: AB_10600921","unprognostic (6.53e-2)","unprognostic (1.27e-1)","unprognostic (1.61e-2)","unprognostic (8.66e-4)","unprognostic (1.41e-2)","unprognostic (1.50e-3)","unprognostic (1.47e-2)","unprognostic (3.11e-2)","unprognostic (1.60e-1)","unprognostic (2.88e-2)","unprognostic (1.20e-1)","unprognostic (1.12e-1)","unprognostic (3.78e-2)","unprognostic (5.49e-2)","unprognostic (1.71e-1)","unprognostic (6.74e-2)","unprognostic (3.04e-1)",5,0,5,10,NA,0,0,NA,NA
"WNT16","","ENSG00000002745","Wnt family member 16","Q9UBV4","7","121325367-121341104","Predicted intracellular proteins, Predicted secreted proteins","Wnt signaling pathway","Developmental protein","","Evidence at protein level","Evidence at transcript level","Evidence at transcript level","Evidence at protein level","Group enriched","Detected in some",4,"cervix: 6.0;skin 1: 20.5","Cell type enhanced","Detected in some",NA,"B-cells: 3.9;Basal keratinocytes: 6.1;Endometrial stromal cells: 3.3;Inhibitory neurons: 5.9;Microglial cells: 3.6;Suprabasal keratinocytes: 6.3","Cancer enhanced","Detected in some",NA,"lung cancer: 1.1","Not detected","Not detected",NA,"","Group enriched","Detected in some",145,"memory B-cell: 15.6;naive B-cell: 15.4","Lineage enriched","Detected in single",146,"B-cells: 15.6","Cancer enhanced","Detected in some",NA,"Leukemia: 10.0","Colon - Enteric glia cells","Low region specificity","Detected in single",NA,"","Region enhanced","Detected in some",NA,"spinal cord: 4.4","","","","","","Secreted to extracellular matrix",NA,NA,NA,NA,"Cluster 19: B-cells - Humoral immune response","Cluster 61: Skin - Cornification","Cluster 23: B-cell cancers - Adaptive immune response","Cluster 37: Neurons - Neuronal signaling","","","","unprognostic (6.53e-2)","unprognostic (3.63e-2)","unprognostic (7.24e-2)","unprognostic (1.90e-2)","unprognostic (2.94e-3)","unprognostic (5.23e-2)","unprognostic (1.77e-2)","unprognostic (1.16e-1)","unprognostic (1.12e-1)","unprognostic (1.94e-1)","unprognostic (3.77e-1)","unprognostic (2.18e-2)","unprognostic (3.57e-10)","unprognostic (5.89e-3)","unprognostic (2.73e-1)","unprognostic (5.50e-2)","unprognostic (1.66e-1)",8,8,6,22,"ENST00000222462; ENST00000361301",0,1,NA,NA
"WNT5A","hWNT5A","ENSG00000114251","Wnt family member 5A","P41221","3","55465715-55490539","Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins","Chondrogenesis, Differentiation, Wnt signaling pathway","Developmental protein","Disease variant, Dwarfism","Evidence at protein level","Evidence at transcript level","Evidence at protein level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"endometrium 1: 27.4;salivary gland: 34.4","Cell type enhanced","Detected in many",NA,"Club cells: 53.4;Endometrial stromal cells: 92.8;Serous glandular cells: 60.3","Low cancer specificity","Detected in all",NA,"","Low region specificity","Detected in all",NA,"","Not detected in immune cells","Not detected",NA,"","Not detected","Not detected",NA,"","Cancer enhanced","Detected in many",NA,"cervical cancer: 182.9","Liver - Hepatocytes","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","","","","","","Secreted to extracellular matrix",NA,NA,NA,NA,"","Cluster 12: Smooth muscle tissue - Mixed function","Cluster 20: Connective tissue cells - ECM organization","Cluster 21: Serous glandular cells - Salivary secretion","","","","unprognostic (2.34e-3)","unprognostic (1.35e-1)","prognostic favorable (2.94e-5)","unprognostic (1.37e-1)","unprognostic (3.45e-3)","unprognostic (1.14e-1)","unprognostic (2.16e-2)","unprognostic (3.91e-2)","unprognostic (5.89e-2)","unprognostic (9.58e-2)","unprognostic (8.34e-3)","unprognostic (1.10e-1)","unprognostic (4.81e-3)","unprognostic (9.70e-3)","unprognostic (2.40e-1)","unprognostic (5.42e-3)","unprognostic (3.63e-2)",11,5,12,28,"ENST00000474267; ENST00000493406",1,0,NA,NA
"WNT5B","","ENSG00000111186","Wnt family member 5B","Q9H1J7","12","1529891-1647212","Predicted secreted proteins","Wnt signaling pathway","Developmental protein","","Evidence at protein level","Evidence at transcript level","Evidence at transcript level","Evidence at protein level","Tissue enhanced","Detected in many",NA,"prostate: 32.4","Cell type enhanced","Detected in many",NA,"Basal squamous epithelial cells: 19.5;Club cells: 20.5;Microglial cells: 19.2;Muller glia cells: 34.5;Prostatic glandular cells: 18.3;Salivary duct cells: 23.6","Cancer enhanced","Detected in all",NA,"testis cancer: 15.8","Low region specificity","Detected in all",NA,"","Immune cell enhanced","Detected in some",NA,"classical monocyte: 1.8;eosinophil: 1.5","Low lineage specificity","Detected in many",NA,"","Low cancer specificity","Detected in many",NA,"","Kidney - Fibroblasts, Liver - Hepatocytes, Thyroid - Fibroblasts","Low region specificity","Detected in all",NA,"","Low region specificity","Detected in many",NA,"","HPA061991","","","Approved","Vesicles","Secreted to extracellular matrix",NA,NA,NA,NA,"Cluster 45: Eosinophils - Innate immune response","Cluster 12: Smooth muscle tissue - Mixed function","Cluster 20: Connective tissue cells - ECM organization","Cluster 53: Connective tissue cells - ECM organization","Vesicles","","HPA061991: ","unprognostic (7.44e-2)","unprognostic (5.59e-2)","unprognostic (8.14e-2)","unprognostic (3.69e-2)","unprognostic (1.12e-1)","unprognostic (1.45e-1)","unprognostic (5.53e-3)","unprognostic (1.26e-1)","unprognostic (1.10e-1)","unprognostic (3.02e-2)","unprognostic (4.08e-2)","unprognostic (2.16e-2)","unprognostic (1.49e-3)","unprognostic (1.90e-1)","unprognostic (2.93e-2)","unprognostic (2.77e-1)","unprognostic (2.71e-2)",12,0,8,20,NA,0,0,NA,NA
